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The Utility of Patient-Specific CT Dose Estimation Map 
 
 
 
Carla M. Thompson 
ABSTRACT 
 
Publicized radiation overdoses in computed tomography (CT) imaging sparked 
concern for the amount of radiation patients receive from CT examinations. Limitations 
exist with accurately estimating patient radiation dose from CT. However, traditional 
dose descriptors do not take into account patient-specific anatomy and are therefore 
limited in providing accurate dose estimates for individual patients. This dissertation 
describes the development and validation of patient-specific dose maps which display 
pixel values equal to the dose absorbed by corresponding tissue voxels and the potential 
utility of dose maps over standard dose estimation methods.  
Patient-specific virtual phantoms were created from the patient’s own CT images 
by classifying each voxel as a specific material type based on fixed Hounsfield Unit 
threshold values. Using a customized Monte Carlo (MC) tool; x-ray photon interactions 
with the materials were modeled based on specific scanner characteristics. 
Dose maps were validated by comparing radiation dose measurements from 
metal-oxide semiconductor field-effect transistors (MOSFETs) placed in 
anthropomorphic phantoms during CT scanning to simulate dose map dose values. 
Results showed that radiation dose estimated using MC methods were strongly correlated 
with MOSFET measurements.  
vi 
 
Dose maps were created from the CT images of 21 obese patients referred for the 
evaluation of cardiovascular disease. Effective dose (E) determined from the standard 
dose-length product conversion method was compared to E determined from dose maps 
using International Commission of Radiological Protection publication 60. Dose maps 
derived from patient CT images yielded lower E estimates than DLP conversion methods.  
The influence of iodinated contrast, routinely injected prior to CT data 
acquisition, on absorbed radiation dose was explored in a separate patient cohort. Dose 
maps were created to compare organ doses with CT image acquisition before and after 
intravenous contrast media administration. Results showed that absorbed radiation dose 
from CT scanning was higher in the presence of contrast.  
This work demonstrated that dose maps provide more accurate dose estimates that 
account for patient size, individual organ sizes, differences in body composition, and the 
presence of iodinated contrast. Wide-spread availability of simulation tools for all 
scanner platforms would enable more patient-specific dose estimation than traditional, 
patient-generic metrics.  
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CHAPTER I 
INTRODUCTION 
 
 
Although millions of people have benefited from computed tomography (CT) 
exams, the risk from radiation exposure is a concern especially when radiosensitive 
organs like the breast and lungs are in the scan range [1]. Accurate estimation of radiation 
dose to patients during CT scanning is currently limited. Traditional methods for 
estimating dose are plagued with inherent errors stemming from the use of physical, 
cylindrical phantoms to represent patients during actual CT scanning. Sophisticated 
Monte Carlo (MC) methods have been used to combat the limitations of physical 
phantoms by modelling computational phantoms that better represent the human body. 
However, a 70 kg reference computational phantom is typically used which does not 
represent all patients well. Radiation dose to a specific patient will be either over- or 
underestimated for those individuals whose body size differs from the reference size 
phantom.  
Differences in overall patient size, individual organ sizes, and body composition 
should be considered to help improve the accuracy of dose estimation methods. The 
American Association of Physicists in Medicine (AAPM) attempts to address this need 
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by suggesting patient size-based modification of scanner-provided volume CT dose index 
(CTDIvol) values [2]. The report provided correction factors based on a patient’s 
estimated effective diameter that can be used to determine a size-specific dose estimate 
(SSDE) [2].  
Patient-specific 3D anatomical dose maps have the potential to provide more 
accurate organ dose and effective dose (E ) estimates. Patient-specific dose maps capture 
the variations in human anatomy and body size. Anatomical dose maps are generated by 
performing MC simulations on virtual phantoms created from patient CT data rather than 
a standard reference phantom or anthropomorphic phantom. CT radiation exposure can 
be simulated for a specific patient and scan protocol.  
In addition to neglecting patient-specificity, dose descriptors (CTDI, SSDE, dose-
length product (DLP), E derived from the DLP conversion method (EDLP)) also fail to 
account for the effect of iodinated contrast on organ dose. The effect of the presence of 
iodinated contrast agent in the vessels during scanning on radiation dose to the organs is 
not well understood. Additional radiation could be absorbed by blood due to the 
increased attenuation of x-rays by iodine thereby sparing dose to the organs. 
Alternatively, the increased attenuation of x-rays by blood could lead to increased energy 
deposits in the organs. The extent of iodine uptake by the organs at the time of scanning 
also influences radiation dose [3, 4].  
The goal of this work is to explore the utility of patient-specific cardiovascular 
CT dose maps. Specific Aim 1: To evaluate the hypothesis that MC methods performed 
on CT images of an anthropomorphic phantom can accurately estimate organ dose to the 
phantom. Specific Aim 2a: To evaluate the hypothesis that patient-specific CT dose maps 
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characterize variability in breast and lung dose of obese patients. Specific Aim 2b: To 
evaluate the hypothesis that CT E is overestimated for obese patients when standard dose 
estimation methods are employed. Specific Aim 3: To evaluate the hypothesis that dose 
maps have the ability to quantify radiation dose in the presence of iodinated contrast.  
This dissertation is organized as background (chapters 2-7), preliminary work 
(chapter 8) and the results of specific aims (chapter 9-11). Chapter II explains the 
formation of x-rays and x-ray interactions. Chapter III introduces computed tomography 
along with data acquisition and the components of image reconstruction. Chapter IV 
describes standard dose descriptors used in a clinical setting. The types of computational 
phantoms are explained in chapter V. Three types of dose detectors are discussed in 
chapter VI. Chapter VII introduces Monte Carlo methods and highlights three types of 
Monte-Carlo based dose calculators. 
Chapter VIII describes the details of the preliminary studies to validate MOSFET 
technology and compute calibration factors for eventual validation of dose maps. This 
chapter also presents initial work on the creation and characterization of dose maps. 
Segmentation of organs and evaluation of breast and lung dose is also discussed. Finally, 
the determination of E from dose maps is described in detail and initial comparisons to E 
derived using traditional methods are made.  
Chapter IX describes the validation process of dose maps using metal-oxide 
semiconductor field resistor transistors (MOSFET) technology. The experimental 
methods, results, and discussion based on the findings are included in this chapter.  
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Chapter X describes the utility of patient-specific dose maps by characterizing the 
variability in breast and lung dose of obese patients and the examination of calculating E 
for obese patient using both the dose map method and standard dose estimation methods.  
Chapter XI explores how radiation dose to a patient is affected by the injection of 
iodine-based contrast media. A new classification scheme that increases the sensitivity of 
dose maps to the amount of contrast agent present during scanning is described. The 
methods, experiments, and preliminary results from a comparison study of the radiation 
dose patients received during non-contrast and contrast-enhanced scans are detailed in 
this chapter.  
This dissertation concludes with a brief summary of the findings and relevance to 
dose estimation methods using patient-specific dose maps.  
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
 
 
 
 
 
CHAPTER II 
X-RAY BASICS 
 
 
2.1 Radiation 
Radiation is energy in motion capable of traveling through space or matter. 
Electromagnetic (EM) radiation is a type of radiation used in diagnostic imaging. X-rays 
are a form of EM radiation, produced outside of the nucleus [5]. Nonionizing radiation 
carries low energy (visible light, radio waves, and microwaves) that can excite electrons 
to a higher energy state without displacing them [6]. Ionizing radiation carries high 
energy (ultraviolet, x-rays, and gamma rays) that are capable of removing an orbital 
electron from an atom. This type of radiation can potentially alter deoxyribonucleic acid 
(DNA).  
 
2.1.1 Creation of X-rays 
Inside of an enclosed vacuum, x-rays are produced when a high voltage is applied 
between two electrodes (cathode and anode). The acceleration of electrons from the 
cathode (negatively charged) to the anode (positively charged) is due to the electrical 
potential difference. Tungsten is a popular anode material because of its high atomic 
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number and high melting point which allows efficient x-ray production [5]. This material 
can also handle high amount of deposited heat. When electrons hit the target material, the 
majority of kinetic energy (KE) of the electrons is converted into heat and a small 
percentage is converted into x-rays [5]. Depending on the chosen target material, the 
electron shell that exist around the nucleus corresponds to different energy levels (K 
shell, L shell, and M shell) [5, 6]. The target material with a high atomic number 
increases the probability of electron interactions to produce higher energy x-rays [5]. 
Therefore the chosen target material will determine energy of the x-rays produced.  
 
2.1.1.1 Tube Potential 
Tube potential, in units of kilovoltage (kVp), is the electrical potential difference 
applied between the cathode (source) and anode (target) in an x-ray tube allowing the 
flow of electrons from the source to the target. Tube potential determines the energy of 
the x-ray beam. Therefore, increasing the tube potential also increases the energy of x-
rays which allows for easier penetration of tissues and a reduction of noise in the image. 
Increasing the tube potential also increases radiation dose; dose is proportional to the 
square of the tube potential [7]. A selection of discrete tube potentials available on a CT 
scanner includes these typical values: 70, 80, 100, 120, and 135. 
 
2.1.1.2 Tube Current 
Tube current, in units of milliampere (mA), is the number of electrons flowing from the 
cathode to the anode per unit of time. The product of tube current and x-ray on time is the 
tube current-time product expressed in unis of millimpere-seconds (mAs). Tube current 
and tube current-time product are directly related to the amount of radiation delivered to a 
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patient. By lowering the tube current (keeping other parameters constant) radiation dose 
will be decreased but noise will increase since fewer x-rays will be produced and reach 
the detector.  
 
2.2 Generation of X-rays 
X-rays are generated through two electron interactions processes: bremsstrahlung 
radiation and characteristic radiation. 
 
2.2.1 Bremsttrahlung Radiation 
Bremsttrahlung radiation is characterized as a series of electron interactions with 
the atomic nucleus of the target material. Most x-rays are created by this method. The 
Coulombic attraction between the nucleus and the electron causes the electron to 
decelerate and change direction [5]. A close interaction will yield a higher energy x-ray 
whereas an interaction at a greater distance from the nucleus will yield lower energy x-
rays. High energy x-rays are the result of the electron directly striking the nucleus and a 
loss of electron’s KE. A large distance from the electron to nucleus results in a weak 
Coulombic force, hence a low energy x-ray. Coulombic forces acting on the electron 
increases when the distance to the nucleus is close causing a shift in the electron’s 
direction and producing a higher energy x-ray (larger loss of KE) [5]. When multiple 
electrons undergo Bremsstrahlung interactions, the result is a continuous spectrum of x-
ray energies. 
The majority of the x-rays produced in Bremsstrahlung are low energy x-rays 
because the majority of interactions take place at a greater distance from the target 
nucleus. The unfiltered Bremsstrahlung spectrum shows a linear decrease in the 
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production of x-rays with increasing energy up to a maximum energy determined by the 
peak tube potential applied to accelerate electrons toward the target. The lowest energy x-
rays and the average x-ray energy varies from one-third to one-half of the maximum x-
ray energy [5].  
 
2.2.2 Characteristic Radiation 
Characteristic radiation occurs when an accelerated electron causes the removal of 
an electron (ionization) from the K shell (innermost shell). This causes a vacancy that has 
to be filled from an electron residing in another shell (L or M) because an unfilled shell is 
unstable. Each electron in the target atom has a binding energy that depends on the shell 
in which it resides. The K shell (closest to the nucleus) has the highest binding energy 
followed by L, M and so forth. The chosen target material will determine the specific 
electron binding energies of the electron shell, hence the emitted x-rays will have discrete 
energies characteristic of the anode material [5, 6]. Excess energy is released as a 
characteristic x-ray when the electron moves to a lower energy level. This process results 
in production of an x-ray photon with energy equal to the difference between the two 
electron shells [5, 6].  
 
As electrons move from higher to lower energy levels to fill a vacancy, several 
discrete energy peaks are superimposed on the continuous Bremsstrahlung spectrum. The 
energy level that receives the electron is designated by a characteristic x-ray with a 
subscript alpha ( α ) or beta (β) where α indicates adjacent transition and β indicates a 
nonadjacent transition [5]. For example, Kα implies that the electron moved from L to the 
K shell and Kβ implies that the electron moved from M, N, or O shell to K shell [5]. 
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Characteristic K x-rays are emitted only when the electrons colliding with the target 
exceed the binding energy of a K shell electron. The tungsten target produces a K 
characteristic x-ray when the acceleration potential is greater than 69.5 kVp [5]. 
Characteristic x-ray production is described as an electron-electron interaction whereas 
Bremsstrahlung is an atom-electron interaction. 
 
2.3 X-ray Interaction with Matter 
X-rays interact with matter in three primary ways: Rayleigh scattering, Compton 
scattering, and photoelectric absorption. These interactions will determine the path of the 
x-ray photon. 
 
2.3.1 Rayleigh Scattering  
Rayleigh scattering occurs mainly when very low energy x-rays interact with and 
excite the total atom causing electrons to vibrate in phase. The lower energy electron 
returns to its previous energy level by emitting a photon of the same energy but in a 
slightly different direction. In this interaction, no absorption of energy occurs (ionization 
does not occur) and the majority of the x-ray photons are scattered at a small angle [5, 8]. 
The probability of this type of scattering occurring is low, about 5% because of the low 
effective atomic number of soft tissues [8]. The probability increases as the atomic 
number increases and the x-ray energy decreases.  
 
2.3.2 Compton Scattering 
Compton scattering occurs when a high energy incident photon (EO) causes the 
ejection of valence electron from the outer orbital shell and the electron is scattered with 
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some energy (Ee-). Simultaneously, a photon is scattered (Esc) with reduced energy. The 
conservation of energy is preserved when the energy of the incident photon is distributed 
as the sum of KE of the ejected electron and the energy of scattered photon [5]. 
EO= Ee-+ Esc     (2-1) 
Momentum is also conserved in this collision and it can be shown that the 
wavelength of the scattered photon (λʹ) is related to the wavelength of the incident photon 
(λ), where me is the mass of the electron and h is Planck’s constant. 
𝜆′ − 𝜆 =
ℎ
𝑚𝑒𝑐
(1 − 𝑐𝑜𝑠 𝜃)         (2-2) 
      𝜆𝐶𝑜𝑚𝑝𝑡𝑜𝑚 =
ℎ
𝑚𝑒𝑐
= 2.4𝑥10−12 𝑚               (2-3) 
Therefore, this type of scattering results in the ionization of the atom and the loss 
of KE via excitation and removal of electron. An increase in energy of the incident 
photon will increase the scattering of both the scattered photon and electron. The majority 
of the energy is transferred to the scattered electron when high energy incident photons 
interact with a valence electron. At most diagnostic photon energies, Compton will 
dominate in materials of lower atomic number such as soft tissue and air.  
 
2.3.3 Photoelectric Effect 
Photoelectric effect occurs when the incident photon energy is transferred to an 
inner shell electron resulting in the ejection of an electron (Ee-) where KE is equal to 
difference of the incident photon energy (EO) and the electron binding energy (Eb). The 
inner shell electron has a binding energy similar to but less than the energy of the incident 
photon [5, 8]. 
Ee = EO – Eb     (2-4) 
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The ionization of the atom creates a vacancy in which an electron from a higher 
energy level fills the lower level vacancy but creates another vacancy in the process. This 
vacancy is also filled from another higher binding energy shell. This process leads to an 
electron cascade where electrons transition between different energy shells. The result of 
a photoelectric interaction is the production of a photoelectron, positively charged ion 
(atom lacks an electron), and characteristic x-rays from lower energies [8]. An increase in 
the photon’s energy decreases the probability of photoelectric effect occurring. Image 
contrast is improved with photoelectric interaction because the process amplifies 
differences in attenuation between tissues with different atomic numbers [5, 8]. For 
example, this process dominates when lower energy photon (i.e., tissue) interact with 
high atomic (Z) materials (i.e., iodine).  
 
2.4 Attenuation 
Attenuation is the removal of photons from an x-ray beam as it passes through matter. 
This is due to absorption and scattering of photons. 
 
2.4.1 Linear Attenuation Coefficient 
Linear attenuation coefficient (µ) is defined by the portion of photons removed 
from a monoenergetic beam of x-rays per unit thickness of a material expressed in units 
of (cm
-1
). An exponential relationship exists between the number of incident photons (N0) 
and those that are transmitted (N) through a thickness of material (x) for a monoenergetic 
beam of photons:  
N = N0e
-µx
     (2-5) 
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The linear attenuation coefficient is the sum of the individual linear attenuation 
coefficients based on different type of interactions of x-rays with matter:  
µ = µRayleigh + µPhotoelectric effect + µCompton scatter + µpair production  (2-6) 
The linear attenuation coefficient is dependent on the incident x-rays that is traveling 
through the thickness of a material and the density of the material [5, 8].  
 
2.4.2 Mass Attenuation Coefficient 
Mass attenuation coefficient is defined as the linear attenuation coefficient per 
density (ρ) expressed as (µ/ρ). Mass attenuation coefficient is independent of density of 
the material. The linear attenuation coefficient varies for the same material if it has 
different physical densities whereas; the mass attenuation coefficient stays the same for a 
material in different states. [8]. For example, water, vapor, and ice have the same mass 
attenuation coefficient because it normalizes the linear attenuation coefficient by the 
density of the material [8]. 
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CHAPTER III 
Computed Tomography Basics 
 
 
3.1 Computed Tomography 
Computed tomography (CT) is one of the medical imaging modalities that require 
ionizing radiation to image patients. An x-ray source and detector rotate around the 
patient generating cross-sectional images. The rotating x-ray tube allows for multiple x-
ray projections taken at different angles. Each table position allows a different slice of 
tissue in the path of the x-ray beam to be captured for acquisition.  
Multi-detector row CT (MDCT) scanners have multiple detector rows in the 
longitudinal (z-axis) direction enabling acquisition of multiple images with a single 
gantry rotation. The most modern scanners have 64, 128, 256, or 320 detector rows. 
 
3.1.1 Data Acquisition 
MDCT data are acquired with either a sequential (axial or step-and-shoot) or 
spiral (helical) scanning mode. In axial mode, the gantry rotates around the patient (360 
degrees) while the patient table is stationary and then the patient table is incremented (in 
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z-direction) to the next position. This process is repeated until the entire anatomy of 
interest is scanned.  
In helical mode, the gantry continuously rotates around the patient with 
simultaneous movement of the patient table. The creation of slip ring technology allowed 
continuous rotation without having to stop gantry rotation. During helical scanning, 
attenuated photons pass through any given slice of the patient’s body striking each 
detector row in succession as the patient table moves through the gantry. Pitch is only 
associated with helical scanning and it is defined as the ratio of table travel (mm) per 
gantry rotation to total nominal beam width (mm) [9]. An increase in pitch (1>) will 
result in less overlap in data acquisition in the z-direction, whereas a decrease in pitch 
(<1) will results in more overlap in data acquisition [9].  
 
3.1.2 Image Reconstruction 
Attenuation is the removal of photons from an x-ray beam due to absorption and 
scattering of photons. Each attenuated x-ray that is acquired in CT travels through the 
patient along a line between the source and the detector. The detector measures the x-ray 
intensity (I) from each attenuated and unattenuated x-ray. The intensity of x-rays that are 
unattenuated, Io, are measured by a reference detector and the following equation shows 
the relationship between I and Io: 
I = Io e
-µx
     (3-1) 
where x is the thickness of the patient along the ray (in centimeters) and µ is the average 
linear attenuation coefficient along the ray (in cm
-1
). This data is used to calculate the 
projection data, P(x) which is independent of the intensity of the x-ray beam.  
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                                                                        𝑃(𝑥) =  ln (
𝐼𝑜
𝐼
)     (3-2) 
Combined results characterized as 
ln (Io/I) = µx      (3-3) 
P(x) = µx      (3-4) 
Taking the logarithm provides a signal that is linearly related to the characteristic of the 
material being measured. X-rays decrease in intensity exponentially as they pass through 
material. The linear attenuation coefficient is determined by composition and density of 
the tissue inside of each voxel in the patient and is the total attenuation coefficient for 
each x-ray summarized as 
µx = µ1Δx + µ2Δx + µ3Δx +…. + µnΔx    (3-5) 
 
where Δx is the small path length, which factors out from the above equation: 
µx = µ1 + µ2 + µ3 +…. + µn      (3-6) 
The reconstructed value in each pixel is the linear attenuation coefficient for the 
corresponding voxel where µx is the sum of attenuation coefficients µj of all materials 
along a single x-ray.  
 
3.1.2.1 Filtered Back Projection 
After preprocessing of the raw data, a CT reconstruction algorithm is used to 
produce CT images. Back projection (BP) is the most widely used reconstruction 
algorithm in clinical CT scanners. BP utilizes a mathematical process to reverse the 
image acquisition by smearing each projection back across the reconstructed image. The 
algorithm knows the acquisition angle and position in the detector array corresponding to 
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each ray. This process produces blurred images and the data requires a filter before 
reconstruction. Filtering is used during the image reconstruction process. The process of 
using a filter to correct for blurring before reconstruction is known as filtered back 
projection (FBP). Different filters can be applied depending on the diagnostic purpose. A 
smooth filter is helpful for viewing soft tissues and a sharp filter is ideal for higher 
attenuating tissues.  
Fourier Transform (FT) converts projection data in the spatial domain into the 
frequency domain. Frequency domain data is multiplied by a filter function (K(f)) and 
then transformed back into the spatial domain using the Inverse Fourier transform (FT
-1
). 
This relationship is represented as 
p’(x) = FT-1 [FT[p(x) * K(f)]]     (3-7) 
where p(x) is the unfiltered data in the spatial domain and p’(x) is the filtered data in 
spatial domain. Once the data is filtered, it is ready to be backprojected allowing for 
recreation of the object scanned. An image matrix is obtained of the scanned volume and 
a numerical value (between 0 and 1) is assigned to each pixel in the image. This value 
indicates the average of all the attenuation values contained within the corresponding 
tissue voxel. 
 
3.1.2.2 Iterative Reconstruction 
Iterative reconstruction (IR) is an increasingly prevalent CT image reconstruction 
method that assumes an initial attenuation coefficient for all voxels and uses these 
coefficients to predict projection data. This predicted projection data is compared with 
the actual measured data and an updated image is computed. Voxel attenuation values are 
repeatedly modified until the error between the estimated and measured projection data is 
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acceptable. This method is more computationally intensive but has been shown to 
significantly improve image quality in comparison to FBP at a given radiation dose. 
 
3.1.3 Image Display 
After CT reconstruction, pixel values are scaled to an integer (see equation below) 
and compared to the attenuation coefficient of water [5]. The CT number of a material is 
the end result in clinical CT images. The attenuation coefficient (µ) values are scaled to 
that of water to compute the CT number and multiplied by a scalar. When the scalar is 
equal to 1000, the CT Number is called a Hounsfield Unit (HU). 
𝐻𝑜𝑢𝑛𝑠𝑓𝑖𝑒𝑙𝑑 𝑈𝑛𝑖𝑡 =  
𝜇𝑡𝑖𝑠𝑠𝑢𝑒− 𝜇𝑤𝑎𝑡𝑒𝑟 
𝜇𝑤𝑎𝑡𝑒𝑟
× 1000     (3-8) 
The range of Hounsfield Units is from +1000 to -1000 for naturally occurring 
tissues in the body (Table 1) [10] . Hounsfield Units are represented on a gray scale [11]. 
Bone is represented by the brightest white color and air is represented by black while 
tissues in between are assigned various shades of gray. 
Tissue Type  HU 
Bone 1000 
Soft Tissue 5 to 40 
Blood 50 to 60 
Water 0 
Fat -200 to -5  
Lung -930 to -200 
Air -1000 
Table 3.1: Various tissues are represented by attenuation in HU. 
 
The appearance of the image can vary by modifying the window width (WW) and 
window level (WL). WW defines the range of grayscale values over which the CT 
numbers are spread. The WL defines the center of the range of grayscale values. 
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Changing the WW affects image contrast and changing the WL affects the 
brightness/darkness of an image [11]. Increasing the WW spreads image CT numbers 
over a larger range of grayscale values producing an image with highlighted bony 
structures but poor tissue differentiation. Decreasing the WW increases the image 
contrast among tissues. The choices of WW and WL will depend on the clinical need.  
 
3.1.4 ECG Synchronization with CT 
Electrocardiographic (ECG) synchronization is necessary for most cardiac CT 
scanning to restrict image data to a desired cardiac phase and is accomplished by using 
the patient’s ECG signal to either prospectively trigger data acquisition or retrospectively 
gate image reconstruction [9, 12]. A slower heart rate allows a longer diastolic window of 
minimal cardiac motion avoiding motion artifacts and improving image quality which is 
important when examining small structures (coronary arteries). Standard CT image 
reconstruction algorithms require 360 degrees of projection data to generate images. 
Special algorithms exist for cardiac imaging requiring only approximately 180 degrees of 
projection data. This means cardiac data can be acquired in less time yielding images 
with better temporal resolution.  
Prospective ECG-triggered axial scanning is often used for cardiac imaging. The 
patient’s ECG signal is synchronized with data acquisition. Detection of the R peak of the 
ECG signal initiates scanning while the table is stationary, then the table is moved to the 
next z-axis position while x-ray emission is stopped; data acquisition is resumed once the 
table is stationary [9, 12]. This process of table movement/data acquisition is repeated 
until the area of interest is scanned.  
19 
 
Retrospective ECG-gated helical scanning is a higher dose approach in 
comparison to prospective ECG-triggered axial scanning but preferred for patients with 
high or irregular heart rates. The patient’s ECG signal is simultaneously recorded as data 
is acquired throughout the cardiac cycle with continuous rotation of the gantry and table 
movement until the entire scan length is covered [9, 12]. This allows reconstruction of 
overlapping images at arbitrary z-positions during any heart phase. CT data is 
retrospectively referenced to the recorded ECG signal and images are reconstructed at 
desired time points within each cardiac cycle [9, 12]. This technique has an increase in 
radiation dose because of a requirement for low pitch imaging (slow table movement).  
 
3.1.5 Contrast Administration with CT  
Most CT imaging protocols require intravenous iodinated contrast agents to 
enhance cardiovascular tissues and organs. These water-soluble agents are iodine-based 
soluble compounds with low toxicity, which are classified as ionic or non-ionic 
compounds [13]. The use of iodine (atomic number = 53) enhances x-ray attenuation [5]. 
The high atomic number of iodine allows for greater absorption and scattering of x-rays 
[13, 14].  
Iodine can accumulate in tissues and organs at different concentrations when 
injected in the body. Contrast enhancement is directly related to the amount of iodine and 
the x-ray energy (governed by the peak tube potential) [14]. A lower potential results in a 
stronger contrast enhancement per iodine concentration. The radiation dose absorbed by 
an organ is dependent on the quantity of iodine accumulated in the organ at the time of 
scan, organ shape, organ volume, and organ position inside of the body [3, 4]. 
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CHAPTER IV 
CT DOSE DESCRIPTORS 
 
 
4.1 Dose Descriptors 
There are four types of dose descriptors that are used to estimate dose: volumetric 
computed tomography dose index (CTDIvol), dose-length product (DLP), effective dose 
(E), and size-specific dose estimate (SSDE).  
 
4.1.1 Computed Tomography Dose Index  
Most clinical CT exams involve multiple gantry rotations. As the x-ray source 
rotates, dose to the irradiated volume is accumulated dose from adjacent scans [15]. 
Multiple scan average dose (MSAD) is the accumulated dose from multiple scan 
examinations averaged over one scan interval in the central region [15, 16]. In 1981, 
computed tomography dose index (CTDI) was introduced to correct for scan spacing and 
estimate MSAD in a standardized method [15, 17, 18]. CTDI100 is defined as dose 
measured during a single axial rotation of the scanner with a 100-mm pencil ionization 
chamber inserted in a standard cylindrical, Plexiglas (polymethyl methacrylate or 
PMMA) phantom (32 cm and 16 cm diameter) [19, 20].  
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CTDI100 is calculated by dividing the integrated absorbed dose from a single axial 
scan at a fixed table position by the radiation beam width [21-24],  
𝐶𝑇𝐷𝐼100 =
1
𝑁𝑥𝑇
∫ 𝐷(𝑧)𝑑𝑧
+50
−50
,    (4-1) 
where N is the number of image sections, each with the nominal thickness T (mm), from 
a single rotation and D(z) is the dose as a function of position along the z axis (axis of 
rotation). Absorbed dose, in units of milligray (mGy), is the amount of energy absorbed 
per unit mass [19, 25]. 
The 16 cm diameter head phantom is used to determine CTDI for children and 
adult head protocols. The 32 cm diameter body phantom is used to determine CTDI for 
adult protocols. The 32 cm diameter phantom used to represent adults is actually much 
smaller than many adult patients.  
Many other CT dose descriptors are derived from CTDI100. The subscript 100 
denotes the measurement length of the pencil ion chamber where measurements are taken 
at the center ( c) and 10 mm below the surface (p) of a phantom [24]. When imaging an 
object, CTDI varies across an axial field of view and generally is a factor of two higher at 
the surface than at the center of the field of view [23]. Weighted CTDI (CTDIw) provides 
an estimate of the CTDI100 averaged across the field of view [15, 26]: 
                  centerperipheryw CTDICTDICTDI ,100,100 *
3
1
*
3
2
                   (4-2) 
where CTDI100,periphery represents an average of measurements at four equally-spaced 
locations around the periphery of the phantom and CTDI100,center represents the 
measurement taken at the center of the phantom.  
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Volumetric CT dose index (CTDIvol) represents dose for a specific exam protocol 
and accounts for any gaps or overlaps between the radiation dose profiles from 
consecutive rotations of the x-ray source [15, 23]. CTDIw represents the average radiation 
dose over the x and y direction whereas CTDIvol represents the average radiation dose 
over all directions (x, y, z) where N is the number of simultaneous axial scans per 
rotation, T is the thickness of one axial scan and I is the table increment per axial scan 
[23, 27]:  
                           wvol CTDI
I
TN
CTDI 

                                     (4-3) 
The CTDIvol is fixed and independent of patient size and scan length thus, CTDIvol does 
not quantify dose to a patient but rather indicates the radiation intensity that is directed to 
patients [28]. 
4.1.2 Dose-length product 
Dose-length product (DLP) is determined by multiplying the CTDIvol with the 
irradiated scan length[22]. DLP reflects the total energy absorbed in a complete scan 
acquisition [27].  
𝐷𝐿𝑃 =  𝐶𝑇𝐷𝐼𝑣𝑜𝑙𝑥 𝐿,      (4-4) 
where L is the scan length (cm) and CTDIvol is retrieved from the CT scanner. 
The CTDIvol and DLP are standardized values provided by the CT scanner to 
estimate and compare dose between protocols on the same scanner or across different 
scanners. Using these standard dose descriptors can underestimate or overestimate dose 
to a patient if the patient size is smaller or larger, respectively, than either the 32 cm 
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diameter (body) or 16 cm diameter (head) cylindrical Plexiglas phantoms used to 
estimate CTDI100 [17].  
It is important to note that dose distribution is non-uniform both within an 
individual CT slice and along a patient [29] which is not captured using an uniform 
phantom to model a patient. Unlike a uniform phantom, a patient has organs and tissues 
that affect dose distribution. 
 
4.1.3 Effective Dose 
Effective dose (E), in units of millisieverts (mSv), is a dose descriptor that reflects 
the biological sensitivity of irradiated organs and tissues. E facilitates the comparison of 
biological risk among different types of imaging examinations [23]. E is intended to 
estimate radiation dose for a population and not for an individual [30], however 
caregivers commonly use E to communicate to patients and each other the amount of 
radiation dose to an individual patient from a specific CT scan [31]. E can be derived 
from organ and tissue absorbed doses or estimated from other CT dose indicators such as 
DLP or CTDI [32]. 
In the clinical setting, E is estimated using the DLP method (EDLP) by multiplying 
a standard conversion factor (k) in units of mSv × mGy
-1
 × cm
-1 
for a particular region of 
the body by the scanner-provided DLP [19] : 
                                                      EDLP = DLP × k                                         (4-5) 
Traditionally, E has been computed for CT scans using pre-tabulated MC 
simulations based on an adult reference phantom. The International Commission on 
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Radiological Protection (ICRP) defines a reference adult as a Caucasian man that is an 
inhabitant of Western Europe or North America weighing 70 kg with a height of 170 
cm[33]. The dimensions for reference man were obtained in the 1970s and 80s [34]. 
Measurements or simulations based on a patient model that utilizes the reference man 
dimensions or Plexiglas phantom with unrealistic anatomy are commonly used for 
estimating dose to radiosensitive organs during CT examinations [30]. 
Estimating E by dose map method (EDoseMap) requires taking the sum of equivalent 
dose (EQ). EQ is calculated by multiplying absorbed dose (D) retrieved from dose maps 
for each organ, i with the appropriate tissue-weighting factor (w).  
         EQi = wi * Di                                              (4-6) 
   𝐸𝐷𝑜𝑠𝑒𝑀𝑎𝑝 =  ∑ 𝐸𝑄𝑖𝑖      (4-7) 
Tissue-weighting factors are meant to represent the relative radiation sensitivity of each 
type of body tissue as determined from population averages over age and sex and are 
derived primarily from the atomic bomb survivors [22]. Since 1977, three different sets 
of tissue weighting factors have been defined by ICRP publications: ICRP 26, ICRP 60, 
and ICRP 103 [35]. The k factors currently used are based on ICRP 60.  
 
4.1.4 Size Specific Dose Estimate 
The American Association of Physicist in Medicine (AAPM) recently described 
the use of size-based conversion factors to determine a SSDE from scanner-reported 
CTDIvol [2]. Conversion factors were generated from studies by four independent 
research groups, which included MC-based dose measurements and physical dose 
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measurements in phantoms. Factors were provided for a range of patient effective 
diameters (mm) for adjustment of CTDIvol values obtained from standard 16- or 32-cm 
diameter PMMA cylindrical reference phantoms.  
Effective diameter can be computed using lateral (LAT) and anterior-posterior 
(AP) patient dimensions:  
                            Effective diameter = APLAT  ,                                     (4-8) 
where LAT is the thickness of the patient from left to right and AP is the thickness of the 
patient from front to back. The conversion factor for conversion of CTDIvol values 
obtained from a 32-cm diameter PMMA phantom is computed using the following 
equation:  
                           Conversion factor = 
 diametereffectivebea  ,                             (4-9) 
where a = 3.70 and b = 0.0367 [2]. The SSDE (mGy) for each patient is then computed 
by multiplying the conversion factor and the CTDIvol (mGy): 
                           SSDE = conversion factor x CTDIvol.                                  (4-10) 
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CHAPTER V 
TYPES OF PHANTOMS 
 
 
5.1 Plexiglas Phantoms 
Plexiglas phantoms simulate the thickness of a patient and are the most commonly 
used phantoms for dose estimation. Usually these phantoms contain holes drilled along 
the central axis in addition to four or eight holes around the perimeter for insertion of 
dosimeters [36]. Limitations associated with using physical phantoms for dose estimation 
include a lack of sampling of age, gender, and patient size which vary in actual patient 
population [37]. 
 
5.1.1 Anthropomorphic Phantoms 
Anthropomorphic phantoms are often made of human skeleton with tissue 
equivalent material simulating soft tissues and usually comprised of vertical stackable 
slices with small holes in each slice for dosimeter placement [37]. Anthropomorphic 
phantoms offer a direct advantage over Plexiglas phantoms by physically representing 
human anatomy with tissue-equivalent materials to account for different tissue 
interactions with radiation [38, 39]. Use of anthropomorphic phantoms permits 
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measurement of organ doses in CT imaging as well as calculation of effective doses. 
Using standard phantoms allows for repeated experiments to make measurements of 
physical quantities using radiation detectors that have been placed on or within the object 
[34]. 
A well-known anthropomorphic dosimetry phantom called ATOM contains resins 
and polymers capable of simulating any tissue in the human body [38] (Fig 5.1). Photon 
attenuation values are within 1% of actual attenuation for soft tissue and bone substitutes 
and within 3% for lung [40].  
 
Figure 5.1: Image of ATOM anthropomorphic phantom [41] [Permission granted 
for reprint] 
 
5.2 Computational Phantoms 
There are three types of computational phantoms: mathematical, voxel, and hybrid. 
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5.2.1 Mathematical Phantoms 
Mathematical (stylized) phantoms (first generation) utilize 3D surface equations 
to characterize planes, spheres, cylinders, cones, and ellipsoids to represent body organs 
[34, 42] (Fig 5.2). Fisher and Snyder at the Oak Ridge National Laboratory (ORNL) 
developed a hermaphrodite (includes both male and female organs) phantom in 1966 
[42]. This group revised the existing phantom to incorporate three different material 
compositions named Medical Internal Radiation Dose (MIRD 5)-type phantoms which is 
based on reference data of ICRP 23 [34, 43]. Another version of mathematical models 
used to represent male and female adults were called ADAM and EVA developed by 
Germany’s National Research Center for Environment and Health (GSF) [44]. These 
phantoms were a modification of the hermaphrodite MIRD5 phantom [34, 43]. Cristy and 
Eckerman integrated the phantoms developed at ORNL and introduced a new series of 
stylized phantoms of various ages (1- year, 5-year, 10-year, 15-year, and an adult) based 
on ICRP publication 23 in 1980 [43].The majority of these phantom models represent an 
‘average or standard individual’ defined by ICRP’s data on the reference man which is 
not representative of Americans today [33, 45]. 
Mathematical phantoms are made simply and intended to represent whole 
populations instead of individual patients [46]. These equations do not accurately 
represent real human organ anatomy which can contribute to over- or underestimation of 
radiation dose. Yet, mathematical phantoms represent an advantage over cylindrical 
Plexiglas phantoms because they more closely resemble a patient and try to account for 
human organ anatomy. 
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5.2.2 Voxel Phantoms 
Voxel (tomographic) phantoms (second generation) are computational models of 
human anatomy [45]. Pixel data from CT images are mapped to 3D volume elements 
(voxels) representative of the shape, volume, and composition of the human anatomy [34, 
47, 48] (Fig 5.2). Each voxel is defined as a material type based on a fixed HU threshold 
value so that it is assigned and identified as belonging to a particular organ or tissue [34].  
Using scanner-specific data and voxel-based computational models can improve 
the accuracy of organ doses derived from mathematical phantom models [45]. Voxel 
phantoms offer a more realistic approach than mathematical phantoms because voxel 
phantoms use the patient’s own CT images and anatomical uncertainties inherent in a 
computational model may be eliminated [45]. But voxel phantoms are less flexible 
regarding permitting changes in body posture and contour, internal organ shape, position 
and depth [49]. 
 
5.2.3 Hybrid Phantoms 
Hybrid phantom (most recent generation of computational phantoms) incorporates 
the reference body dimensions and anatomy from an adult or pediatric CT image in 
compliance with the recommended organ and body dimensions from the ICRP [37, 50] 
(Fig 5.2). Hybrid phantoms use a combination of techniques such as non-uniform rational 
B-spline (NURBS) surfaces, boundary representation (BREP), polygon mesh models to 
make the phantom more realistic [32, 37]. These phantoms were introduced by 
researchers at University of Florida and the National Cancer Institute.  
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NURBS is a mathematical modeling technique commonly used for generating 
curves and surfaces in computer animation [49, 51]. NURBS surfaces provide the 
flexibility to describe and manipulate the boundaries of internal organs and exterior body 
surfaces which is helpful in describing complex tissues structures [49, 51]. Polygon mesh 
models are adapted to NURBS surfaces where 3D control points can be modified to 
permit organ reshaping and repositioning [47]. BREP modelling technique provides more 
anatomically realistic models that also allow deformation of surfaces, which is useful for 
organ motion or sizing and scaling for different body morphometrics [32]. The utility of 
this feature makes it more valuable because simulation of different organ volumes and 
body contours are possible.  
Similar to mathematical phantoms, hybrid phantoms also include a newborn, 1, 5, 
10, 15 year old, adult male and female [50]. The NURBS structures can be filled with 
voxels for any patient size resulting in a hybrid-voxel phantom hence taking advantage of 
both mathematical and voxel phantoms [47]. 
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Figure 5.2: A comparison of computational phantoms: mathematical (stylized), voxel 
(tomographic), and hybrid phantoms [47] (Permission granted for reprint).  
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CHAPTER VI 
RADIATION EXPOSURE AND DOSE DETECTORS  
 
 
6.1 Dose Detectors 
Organ doses cannot be measured directly in patients so physical anthropomorphic 
phantoms are used to simulate the human body. For direct organ dosimetry, 
measurements are performed by placing dosimeters in a physical anthropomorphic 
phantom. Dosimeter measurements can be laborious and time consuming but they 
provide information on dose distributions. Dose detectors include pencil ionization 
chambers, film, thermoluminescent dosimeters (TLDs), and metal-oxide semiconductor 
field effect transistors (MOSFETs). 
Most commonly used dosimeters are TLDs and MOSFETs. Unfortunately, point 
dose measurements cannot accurately represent the average organ dose in cases of high 
dose gradients [37].  
 
6.1.1 Pencil Ionization Chamber 
The ion chamber pencil was developed to measure radiation exposure from a CT 
scan. It is a small-diameter, air-equivalent radiation detector with a varying length of 10-
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15 centimeters (cm) [20]. Chamber readings give exposure in units of roentgens (R) or air 
kerma in units of Gray (Gy) [52]. Pencil ionization chambers are used to investigate and 
measure the shape of the radiation beam width in the z-direction [36]. A radiation dose 
profile produced from the measured radiation beam characterizes the variations along the 
length of the patient or phantom in the z-direction [53]. This measurement represents the 
amount of radiation for a given point in the x-y plane independent of the z-axis for a 
single axial image acquisition [54].  
To achieve accurate readings, ion chambers require calibration to a standard 
reference value. Standard reference values are maintained at the National Institute of 
Standards and Technology (NIST) [52].  
 
6.1.2 Film 
Radiographic film consists of one or two layers of radiation sensitive emulsion. 
This emulsion comprised of silver halide (AgBr and AgI) grains are contained in a gelatin 
base [5]. Radiation interaction with silver halide forms a latent image in the film and the 
image becomes visible during processing [5]. Chemical solutions are used to process 
exposed film which converts the latent image into an image that is visible at different 
optical densities (shades of gray) [55]. The relationship between optical density and 
exposure (measured in milliroentgen) depends on characteristics of the film emulsion and 
the processing conditions.  
A newer type of film, radiochromic is similar to radiographic film except it does 
not require chemical processing and it is self-developing. Polymerization occurs when the 
dye contained in radiochromic film is exposed to radiation [56]. A densitometer measures 
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the transmission of the light through the film when the polymer absorbs light [56]. Using 
an organ volume dosimetry technique, Brady et al showed good agreement between 
radiochromic film and TLD measurements [57]. 
Film provides excellent spatial resolution and can measure exposure at many 
points simultaneously by wrapping the phantom surface which shows qualitative features 
of the surface dose distributions [54]. However, it can be challenging to maintain 
acceptable reproducibility of the entire process including chemical processing and 
uniform film sensitivity [52].  
 
6.1.3 Thermoluminescent Dosimeters 
Thermoluminescent dosimeters (TLDs) come in different forms: powder (crushed 
crystals), solid forms (chips or ribbons) or extruded and embedded in a matrix [52, 54]. 
The literature mostly describes the use of TLDs as crystals comprised primarily of 
lithium fluoride (LiF) [5, 36, 52]. The effective atomic number for LiF is close to that of 
human tissue making it an excellent material choice for phantom dosimetry [5].  
Exposing TLDs to ionizing radiation causes electrons to become trapped in 
excited states [5, 52]. As the TLD is heated, electrons fall to their ground state and energy 
is released by emitting light [5, 52]. This light can be read by a photomultiplier which 
converts light into an electrical signal [5].  
The TLD can be reused by annealing (baking in a high temperature oven). The 
annealing process for TLDs can affect dose measurements; therefore, using TLDs 
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requires meticulous handing to ensure precision and repeatability in measurements [52]. 
TLDs are considered the gold standard for organ dosimetry [38, 57]. 
 
6.1.4 Metal-Oxide Semiconductor Field Effect Transistors 
A metal-oxide semiconductor field effect transistor (MOSFET) is a layered device 
consisting of a source, drain, and a gate built on either n-type or p-type silicon (Si) 
semiconductor substrate [58-60]. The Si substrate is insulated by the polysilicon gate in 
the middle and the silicon dioxide (SiO2) on opposite ends [58, 60].  
Exposure to ionizing radiation generates a significant number of electron-hole 
pairs which become trapped at the Si-SiO2 interface [58, 60]. The buildup of positive 
charges allows current to flow between the source and drain [58-60]. The voltage that 
initiated the current flow between the source and drain of the MOSFET is characterized 
as the threshold voltage [59, 60]. The difference in voltage shift (before and after the 
radiation exposure) is proportional to the total quantity of trapped charges [58]. The 
irradiation of MOSFETs causes a permanent shift in the threshold voltage. This shift is 
proportional to the absorbed radiation dose deposited in the Si-SiO2 making MOSFETs 
useful for CT radiation dosimetry [59]. The magnitude of the difference in voltage shift 
must be calibrated to a known radiation quantity (usually measured with an ionization 
chamber) to ensure accurate dose measurements [58, 60].  
MOSFETs possess excellent spatial resolution and offer little attenuation of the 
beam due to their small size (0.2 mm x 0.2 mm) which is advantageous for phantom 
dosimetry [61]. MOSFETs give point dose measurements and provide immediate dose 
readouts [58]. Newer developed MOSFETs with a high sensitivity bias supply provides 
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an increased dose response suitable for diagnostic energy ranges [62]. Increasing the bias 
voltage could improve sensitivity at low dose measurements [62]. Yoshizumi et al [43, 
45] used a 1.4 mGy for minimum dose detection with a 25% uncertainty. Use of 
MOSFETs for organ dosimetry has been shown to be in good agreement with TLD 
measurements [60, 61, 63].  
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CHAPTER VII 
RADIATION EXPOSURE AND DOSE SIMULATION 
 
 
7.1 Monte Carlo 
Organ doses cannot be measured directly in patients so Monte Carlo (MC) 
methods are performed on a computational anthropomorphic phantoms to simulate the 
human body by taking into consideration CT source, filtration, tube current, and scanner 
geometry [64].  
MC methods are used to determine specific organ doses by simulating the 
absorption and scattering of x-ray photons in various tissues during CT imaging [65, 66]. 
MC simulations are based on detailed information on the source distribution geometries 
(distance between source and center of rotation), x-ray beam shaping filter, x-ray spectra, 
and a computational (mathematical, voxelized, or hybrid) model of the human anatomy 
[67]. Radiation transport is modeled by using Monte Carlo codes incorporating Poisson 
statistics to track individual photon histories. Random distances which a photon travels 
between interactions such as from a source through a medium (i.e., skin) to the detector 
are generated [68, 69]. There are libraries of cross section data for the radiation 
interaction processes for all elements from which the cross section data for body tissues 
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are then evaluated according to their elemental composition and density [46]. Using this 
physical input data, a photon is tracked from its point of creation in the x-ray tube, 
through the patient model. The random interactions of the photons are assigned 
probability functions based on the mass attenuation coefficients of the irradiated tissues 
[70], thus generating a statistically large number of particle histories [45, 68, 69]. The 
probability density is used to detail the particle history. The types of radiation processes 
considered inside of the human body for simulations in medical diagnostic radiology are 
photoelectric absorption and Compton scattering [46].  
With photoelectric absorption, the entire energy of the photon is deposited in the 
voxel. For a Compton interaction, the energy of the scattered photon is absorbed at the 
site of interaction. This process continues until either the photon leaves the volume or its 
energy drops below a certain threshold which results in the photon counted as absorbed 
[70]. This makes it possible to predict properties of the radiation field such as the particle 
fluence, energy deposition, and energy spectrum at particular points [68, 69].  
In the process, all energy depositions are tallied in a corresponding voxelized grid. 
A large number of photon histories are simulated in order to obtain a sufficiently precise 
estimate of the desired dose quantities of interest. Organ doses are determined by 
summing in each organ and tissue all energy depositions from primary and scattered 
photons and dividing by the organ mass. 
MC methods are well-established for accurate CT dose estimation using physical 
phantoms [45, 67, 70, 71], mathematical models [42, 68, 72], voxel models [67, 70, 71, 
73], and hybrid models [47, 74]. Schmidt and Kalender [73] developed and validated a 
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fast voxel-based MC method that yielded dose values from voxelized CT images of 
anthropomorphic phantoms that differed less than 5% from CTDI results obtained with a 
standard MC-based program (EGS4) and published organ dose conversion factors. 
Researchers have validated this approach by comparing dose estimations from 
mathematical or voxel models to those from physical phantoms with MOSFETs or TLDs 
[70, 71]. DeMarco et al [71] showed good agreement between the dose estimated from 
MC methods applied to voxelized images of cylindrical and anthropomorphic phantoms 
compared with the dose determined from physical phantoms using MOSFETs. Deak et al 
[70] found that calculated dose values from 3D dose distributions of voxelized phantom 
images were within 10% of all phantom measurements (Alderson-Rando and cylindrical 
CTDI phantoms) using TLDs. It has been reported that using computer simulations for 
estimating dose offers a more reliable way to obtain accurate organ doses compared to 
using physical phantoms for dose estimation.[75] 
MC methods have been shown to be extremely accurate as they are utilized in 
radiation therapy treatment planning [76]. Unlike DLP-derived dose estimates, MC 
simulation permits organ dose estimation and can account for the impact of iodine 
accumulation on dose [3, 4]. Individual organ dose contributes to the E value and can be 
used to assess radiation risk from diagnostic imaging procedures [77]. However, 
differences between human models and actual patients, as well as variations in scanner 
geometries and X-ray beam spectra, contribute to inaccuracies in organ dose estimation 
with MC methods [78],[74]. Statistical uncertainty is also inherent in the calculated 
doses, depending on the frequency and homogeneity of the random interaction events in 
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an organ. Large organs within the beam are characterized by small uncertainties, whereas 
small organs outside the beam may have large statistical errors [48].  
 
7.2 Monte Carlo-based Dose Calculators 
In 1991, two comprehensive organ dose databases were developed; National 
Radiological Protection Board (NRPB) in London and National Research Center for 
Environment and Health (GSF) in Germany based on Monte Carlo simulations that exist 
in accordance to reference dimensions of the body and organs defined by the ICRP [37, 
50]. NRPB published a report (NRPB-SR250) providing tables of organ dose 
coefficients, normalized to a free-in-air axial scanning of an adult mathematical phantom 
[24]. Additional software is required to manipulate data to estimate doses for various 
scanner protocols. The NRPB report provided 23 datasets with various exposure 
conditions relevant to 27 scanner models (5 manufacturers) that were current during the 
early 1990s [24]. The NRPB organ database was based on a hermaphrodite mathematical 
phantom whereas the GSF database was based on male and female mathematical 
phantoms called ADAM (weight=70 kg, height=170 cm) and EVA (weight=60 kg, 
height=160 cm) and two pediatric (8 week old classified as BABY and a 7 year old 
classified as CHILD) voxel phantoms [37, 78-80]. The NRPB database was later updated 
to include a complete family: 6 mathematical phantoms (newborn, 1 year, 5 year, 10 year, 
15 years, and adult) [24, 68]. Meanwhile at GSF, a complete voxel family was also 
developed representing a range of patient sizes and ages from 8 weeks to 48 years of age 
including both male and female models [81]. Hence, both databases have been updated.  
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Both NRPB and GSF datasets provide organ absorbed dose data normalized to the 
CTDI measured in air at the isocenter (CTDIair) of the CT scanner which are dependent 
on the type of scanner modelled in the MC simulation [82]. The NRPB dataset can be 
used to estimate average organ doses, ICRP values of organ masses, and E [44]. 
Graphical user interface software programs (CT-EXPO, CTDOSIMETRY, CTDOSE, 
WINDOSE, and IMPACT) are based on two organ databases (NRPB and GSF). Various 
MC-based dose calculators (ImPACT, CT-EXPO, ImpactDOSE) exist to estimate organ 
and effective doses for a reference person of standardized size and shape depending on 
the type of scanner used [32]. 
 
7.2.1 ImPACT 
The Imaging Performance Assessment of CT scanners (ImPACT) group (London, 
England) developed a patient dosimetry calculator that uses ICRP 60 or 103 tissue 
weighting factors for adult patients undergoing CT exams to calculate E [79, 83] . 
IMPACT uses dosimetry data from NRPB. Modern scanners are handled using an 
ImPACT matching system of dosimetric characteristics of any new scanner to one of the 
available dosimetry data sets [32, 83]. This process combines ratios of phantom CTDI to 
the corresponding ‘in air’ CTDI, known as ImPACT factors [83]. 
 
7.2.2 CT-EXPO 
CT-EXPO (Hannover, Germany) is software package based on GSF organ dose 
database which calculates age-and gender-specific dose values for a CT scan [50, 79]. 
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GSF data set also uses ImPACT method to match new scanners to a set of scanner-
specific correction factors which are related to the available data sets [32].  
 
7.2.3 ImpactDOSE 
ImpactDOSE (Erlangen, Germany) previously known as WinDose is a computer-
based program that calculates organ and E values for various scanning parameters and 
anatomic ranges. Based on MC dose simulations performed with standard 
anthropomorphic phantoms, ImpactDose allows users to select scan parameters (tube 
potential, current, detector collimation width, and pitch) producing a protocol-specific 
dose calculation which takes into account overscanning and overbeaming [64]. The 
computational phantoms used in these calculations represent average males and females 
which differ from any individual patient. This leads to underestimations of E if the 
patient is smaller than the model and overestimation of E if the patient is larger than the 
model [64].  
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CHAPTER VIII 
PRELIMINARY DATA 
 
 
8.1 Validation of MOSFET Technology 
Chapter VIII describes the use of MOSFET technology to evaluate the hypothesis that 
MC methods performed on CT images of an anthropomorphic phantom can accurately 
estimate radiation dose to the phantom. Preliminary work towards this evaluation 
included establishing the ability of MOSFET technology to characterize dose distribution 
from a CT scan using measurements from an ionization chamber placed in a CTDI 
phantom. Preliminary work also included the generation and characterization of dose 
maps.  
 
8.1.1 Pencil Ion Chamber  
A 10 cm ion chamber (10X6; 3CT; Accu-Dose 2186; Radcal, Monrovia, California) 
pencil along with an electrometer was used to measure radiation exposure from the CT 
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scanner which was converted to dose in air. The ion chamber was calibrated to standard 
reference values.  
A dose reading from the ion chamber represented the average exposure over the 
length (l) of the chamber (l= 100 mm) from a single axial radiation dose profile (Fig 8.1).  
 
Figure 8.1: Radiation Dose Profile [15, 17] (Permission granted for reprint) 
The ion chamber reading was expressed as: 
                                                  𝐼(𝑧=0) =
1
𝑓∗𝑙
∫ 𝐷(𝑧)𝑑𝑧
𝑙
2
−
𝑙
2
,                                     (8-1) 
where f (f-factor) is used to convert air kerma to dose in air, f=1 mGy/mGy [21] and l is 
the length of the ion chamber, l = 100 mm. D(z) represents the absorbed dose profile 
along the z- axis.  
8.1.2 Calibration Method 
Calibration of MOSFETs required a 32-cm diameter cylindrical polymethyl methacrylate 
(PMMA) phantom and a 100 mm pencil ionization chamber using a 256- slice CT 
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scanner (iCT Brilliance, Philips Medical Systems, Cleveland, OH). The PMMA CTDI-
phantom contained nine removable acrylic inserts of 1 cm diameter: one hole in the 
center, four at the periphery, and four holes in the inner portion (of 16-cm diameter) (Fig 
8.2). The ion chamber pencil was inserted in each of the nine holes of the CTDI phantom. 
For a single axial acquisition, calibration was performed for three energy levels at 80, 
100, and 120 kVp with a corresponding tube current of 920, 533, and 320 mA 
respectively. A reading was recorded after eight consecutive measurements were 
performed for each CTDI hole. These eight measurements allowed sampling of 360 
degrees of the tube rotation since the starting tube position is unknown and changes for 
each scan.  
 
Figure 8.2: CTDI phantom with ionization pencil placed in the center  
 
MOSFET dosimeters were calibrated to translate voltage readout to absorbed dose. Two 
mobile MOSFET readers were used with high sensitivity MOSFETs (TN-1002RD-H; 
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Best Medical, Ottawa, Canada). Five MOSFETs were attached to each reader. MOSFETs 
were placed inside of the PMMA holders marked with 5 mm increments.  
The MOSFETs were measured when inserted in each of the nine holes (same 
protocol as ion chamber measurements). The beam width (10mm in the z-axis) used for 
calibration satisfied the minimum width required by the Nyquist criterion for MOSFET 
samples. A dose reading was recorded at each location as the MOSFETs were moved 
along the z-axis according to the 5 mm lines labeled on the holder. The MOSFET holder 
contained 21 marked line positions. The holder was moved 21 positions according to the 
lines marked in 5 mm increments which summed to a total of 100 mm. Identical to the 
ion chamber measurements, eight axial scans were performed for each position. A 
Bluetooth wireless device sent the voltage data from the MOSFET readers to a PC laptop. 
An average MOSFET reading was calculated by integrating the dose under the 
curve and compared to an ion chamber reading. Integration was approximated using 
Riemann middle sum (equation 8-2). A calibration factor per hole (CFh) was calculated 
for each of the 9 holes where Mk is a MOSFET reading for position k which corresponds 
to the lines on the holder, dx = 5mm, l = 100 mm and In is a single ion chamber reading 
for that hole:  
                                 

 

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


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2
21,1 2
n
n
k
k
k
k
h
Il
dxM
dxM
CF ,                                  (8-2) 
Then CFh was averaged for each energy level to cover the distribution in the z-axis. CF is 
the average for all nine holes: 
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8.1.3 Findings 
MOSFET calibration yielded CFs for 3 different energies (80, 100, and 120 kVp). The 
CFs calculated for each energy level was close to 3mV/mGy (Table 8-1). Dose 
distributions’ readings based on one CTDI hole position (12:00 position) for 21 different 
locations along the ion chamber length are shown in Figure 8.3. The voltage readings’ 
profile showed a similar radiation dose profile as seen in Figure 8.1. The peak dose value 
represents the dose to the center of the ion chamber (z=0). There is a decline in the dose 
values to the left and right of the peak dose value which represents scattered radiation 
dose of the axial scan. A similar distribution was seen for the different CTDI phantom 
holes; some peaks were lower than the peak displayed in Fig. 8.1 which could be due to 
scattering. 
Tube potential (kVp) 80 100 120 
Calibration Factor (CF) 3.133 2.993 2.874 
Table 8.1: Key parameters for axial scans used for ion chamber and metal-oxide 
semiconductor field effect transistors (MOSFET) measurements and calculated 
calibration factor 
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Figure 8.3: Voltage readings of dose distribution for one hole location in the 
CTDI phantom in the z-axis along the 100 mm length of the ion chamber for an 
axial 120 kVp scan.  
 
8.1.4 Observations 
The CF values were close to 3mV/mGy, which is in accordance with the expected range, 
as advised by the MOSFET manufacturer. Still, there were slight differences in CF values 
for the 3 different energies, consistent with the manufacturer’s claim of MOSFET 
sensitivity to different energy levels. The dose profile showed that MOSFETs can 
characterize the dose distribution well considering heel effect (asymmetry in the dose 
distribution along the z-axis) and scatter. The measurements were similar to the expected 
dose profile of an axial scan, as depicted in the literature.  
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8.2 Creation of Dose Maps 
Data from patients with cardiovascular disease were acquired using a 256-slice 
CT scanner (iCT Brilliance, Philips Medical Systems, Cleveland, Ohio). Patients were 
imaged clinically for a variety of indications including evaluation of the coronary 
arteries, pulmonary veins, or thoracic aorta. Data were acquired using either a 
prospectively ECG-triggered axial or a retrospectively ECG-gated helical technique 
depending on the clinical indication and the patient’s heart rate. X-ray tube potential and 
tube current were chosen based on the patient size. This study was approved by our 
institutional review board with waiver of informed consent and was compliant with the 
Health Insurance Portability and Accountability Act. 
Patient data were used to create dose map volumes displaying pixels as CTDIvol-
normalized absorbed dose values. Scanner configuration and acquisition parameters were 
extracted as input for the MC tool. This permitted modeling of scanner characteristics 
(CT scanner geometry, table geometry, beam collimation, bow-tie filter composition). A 
patient-specific virtual phantom was created by voxelizing each patient’s image set (Fig 
8.4). Tissues were classified into various classes (dependent on user) pre-selected from 
International Commission on Radiation Units and Measurements (ICRU) Report 44 in 
order to represent the patient’s materials and their chemical stoichiometry. Each voxel 
was classified as one of five material types based on fixed Hounsfield unit (HU) 
threshold values: air (-1000 HU), lung (-930 HU), adipose tissue (-200 HU), soft tissue 
(+5 HU), and cortical bone (+400 HU). Each voxel was assigned a molecular formula 
and a mass density estimate based on its attenuation [84].  
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Figure 8.4: Voxelized image of a patient 
A large number of photon histories were simulated to obtain precise estimates 
[85]. The energy deposited in each voxel was computed and tallied in a corresponding 
voxelized grid [85]. The energy imparted (Joules) was divided by the mass (kg) of the 
irradiated tissue to determine the CTDIvol-normalized absorbed dose in each voxel. 
Normalized absorbed dose was multiplied by the scanner-provided CTDIvol (mGy) to 
obtain absorbed dose (mGy).  
8.3 Characterization of Dose Maps 
The impact of patient parameters (e.g. patient size), mode of data acquisition, and 
scan parameters on dose distribution were evaluated. A color scale was used to describe 
the dose levels of the CT data set. Regions of higher dose were designated in a red hue 
where regions of lower dose were designated in a blue hue. CTDIvol-normalized absorbed 
dose values were displayed on the CT images.  
These preliminary dose maps demonstrated differences in dose distribution 
reflecting differences in patient size and body region imaged as well as the scan protocol. 
Obese patients tended to have higher doses in the periphery compared to smaller patients 
who demonstrated an even distribution of dose throughout their anatomy (Fig 8.5). Dose 
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maps showed that smaller patients absorbed a higher amount of radiation to critical 
organs than larger patients for equivalent exposures. Comparing dose distribution from 
two patients of different sizes showed the presence of additional adipose tissue affects the 
breast and lung dose (Fig 8.6). Tissues are exposed to entrance radiation as the tube 
rotates around the patient [53]. X-rays are attenuated by less tissue in smaller patients 
which leads to higher amount of dose in the center versus the periphery of the patient. For 
obese patients, exit radiation is much less intense because of the attenuation of x-rays 
through a greater amount of tissue which is why there is a higher amount of dose in the 
periphery [53].  
Differences in dose distribution were also observed between helical and axial 
scans (Fig 8.7). Helical scans tended to have an even distribution of dose throughout the 
length of the scan. The amount of dose observed at each end of the scanned anatomy was 
less. However, there was an increase in dose where the axial scans overlapped slightly. 
The red circular lines in the last column indicate the approximately 400° rotation of the 
tube needed to complete each axial scan of the array of images on the right (Fig 8.7).  
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Figure 8.5: Two preliminary dose maps show cross-sectional slices through 
the chest of a slim patient (left) and an obese patient (right) where regions of 
higher dose are designated in a red hue and lower doses designated in a blue 
hue. 
 
 
Figure 8.6: A comparison of dose distributions in two different-sized patients 
shows that patient 1 (BMI=45 kg/m
2
) had higher dose in the periphery due to 
the presence of additional adipose tissue compared to patient 2 (BMI = 
28kg/m
2
) who had a higher dose in the lungs due to less adipose tissue.  
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Figure 8.7: Two sets of preliminary dose maps show retrospectively 
electrocardiogram (ECG)-gated axial scans (left) and prospectively ECG-
triggered scans (right) of the chest.  
 
8.4 Approach for Segmenting Organs from Dose Maps 
An approach was developed to segment organs on dose maps in order to evaluate 
individual organ doses and calculate E. A JAVA based program (ImageJ) was chosen to 
segment organs based on its ease of use. Dose maps were read using ImageJ with an 
image type ‘32-bit real’. Organs were manually segmented (Fig 8.8). Segmentation of 
organs completely contained within the scan field was straight forward. Partially 
irradiated organs (e.g, stomach and liver) were also considered because scattering occurs 
during CT exams. An innovative approach to the segmentation of these organs had to be 
developed. 
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Figure 8.8: Segmented lungs for a patient with BMI = 32 kg/m
2
 
 
A correction factor was included for weighted average organ dose based on direct 
and indirect organ exposure of a partially irradiated organ. The weighting factor for each 
organ was linearly proportional to the length (cranial-caudal extent) of the directly and 
indirectly exposed regions (the length of the indirectly exposed region was based on 
estimates of overall organ length). To obtain whole organ doses, the average dose of the 
indirectly irradiated portion of the organ was determined by estimating the organ length 
and modeling the dose fall-off outside the scan range using an extrapolation model (Fig 
8.9). Based on the data from dose simulations, the dose fall-off in the indirect dose region 
was modeled by a linear profile as a function of organ length with a fixed decreasing 
slope of 10% per centimeter relative to the dose in the directly irradiated portion of the 
organ. Indirect dose to the organ was then estimated as the average of the modeled doses 
at the beginning and end of the indirect dose region. 
Let 𝑙 be the total z extent of the organ. Then let 𝑝𝑟 be the relative fraction of the 
organ length included within the directly irradiated region, and 1 − 𝑝𝑟 the relative 
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fraction within the indirectly irradiated region. Further, let 𝐷𝑟 be the dose in the directly 
irradiated region determined from dose maps and let Di be the average of doses at the 
beginning (𝐷𝑟) and end (𝐷𝑑) of the indirect radiation region determined from dose 
modeling. If the linear dose decline with slope 𝑚 is described by 𝐷𝑟 ∙ (1 +  𝑙𝑑  ∙  𝑚) at a 
dose decline length (𝑙𝑑), the average organ dose (Do) can then be estimated as: 
𝐷𝑜 =   𝑝𝑟 ∙ 𝐷𝑟 + (1 − 𝑝𝑟) ∙ 𝐷𝑖  ,       (8-4) 
where 𝐷𝑖 =
𝐷𝑟+ 𝐷𝑟∙(1+(1−𝑝𝑟)∙𝑙∙𝑚)
2
       (8-5) 
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Figure 8.9: (Top) Only a portion of the liver is included in the scan range and 
directly irradiated (yellow). The remainder of the organ absorbs indirect radiation 
(green). (Bottom) A graphical representation of dose to the directly irradiated 
portion and indirectly irradiated portion of an organ is shown.  
 
(1 − 𝑝𝑟)𝑙 
𝑙𝑒𝑛𝑔𝑡ℎ 
(𝑝𝑟)𝑙 
𝑙 
𝐷𝑖𝑟𝑒𝑐𝑡 𝐷𝑜𝑠𝑒 𝑅𝑒𝑔𝑖𝑜𝑛 𝐼𝑛𝑑𝑖𝑟𝑒𝑐𝑡 𝐷𝑜𝑠𝑒 𝑅𝑒𝑔𝑖𝑜𝑛 
𝐷𝑑 
𝐷𝑟 
𝐷𝑖 = (𝐷𝑟 + 𝐷𝑑)/2 
𝐷
𝑜
𝑠𝑒
 
𝐷𝑟 ∙ (1 +  𝑙𝑑  ∙  𝑚) 
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A CTDIvol-normalized absorbed dose value was retrieved for each segmented organ. 
Normalized absorbed dose was multiplied by the scanner-provided CTDIvol (mGy) to 
obtain absorbed dose (mGy). 
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CHAPTER IX 
DOSE MAP VALIDATION 
 
 
9.1 Introduction 
A strong motivation exists for improving the current methods of estimating 
radiation dose to patients who undergo CT examinations. MC methods provide a 
powerful computational tool to simulate radiation dose for wide range of applications 
including radiation therapy and CT scans [86]. MC techniques can generate dose 
distributions by simulating a large number of particle histories as they emerge from the 
source of radiation and multiple scattering interactions both inside and outside the 
patient. MC methods have been shown to be highly effective in estimating dose 
distributions.  
Many multipurpose MC packages are used to simulate ionizing radiation for 
dosimetry in phantoms: Electron Gamma Shower (EGS), EGS national research council 
(EGSnrc), general Monte Carlo N-Particle transport code (MCNP), and Geometry and 
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Tracking (GEANT4) system. Most of the MC packages have freely available executable 
software but making any modifications to the software is limited [70]. Generally, MC 
simulations have only been validated for older single-slice CT scanners [32, 87]. Some 
MC tools have been used to simulate radiation dose from newer single-source, 64-slice 
scanners [71, 88, 89] but the accuracy of such tools for the newest CT scanners is largely 
unknown. 
We evaluated the accuracy of dose calculations from MC simulations performed 
on an anthropomorphic phantom for a range of CT scan protocols using metal-oxide 
semiconductor field-effect transistor (MOSFET) dosimeters placed inside the phantom.  
 
9.2 Materials and Methods 
9.2.1 Anthropomorphic Phantoms 
An adult phantom (ATOM 701; CIRS, Norfolk, VA) and a pediatric phantom 
(ATOM 704-D; CIRS, Norfolk, VA) containing tissue-equivalent polymers and resins 
capable of simulating any tissue in the human body was used. Phantom photon 
attenuation values are within 1% of actual attenuation for soft tissue and bone substitutes 
and within 3% for lung. Both phantoms are divided into 25 mm contiguous sections each 
containing 5 mm holes for MOSFET placement. Medium-size tissue equivalent breast 
attachments were added to the phantom to assess female adult dosimetry. 
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9.2.2 CT Scanning 
All scanning was performed on a 256-slice CT scanner (Brilliance iCT, Philips 
Healthcare, Cleveland, OH). Scan protocols included standard brain, cardiac, chest, 
abdomen and chest-abdomen-pelvis protocols covering the appropriate phantom anatomy 
(Table 9.1). Each scan was repeated five times for each phantom. 
 
9.2.3 MOSFET measurements 
Ten mobile MOSFET readers were used with high sensitivity MOSFETs (TN-
1002RD-H; Best Medical, Ottawa, Canada). Five MOSFETs were attached to each reader 
and MOSFETs were placed in 50 different locations in each phantom. MOSFET readings 
were recorded after each CT scan and averaged for each MOSFET location.  
 
9.2.4 Monte Carlo simulations 
MC simulations were implemented using Diagnostic Photon Simulations (DiPhos, 
Philips Research, Eindhoven, Netherlands) and performed for each CT scan. For each CT 
scan, 60 projections were simulated to keep simulation time manageable per tube rotation 
with approximately 10,000 photons generated per projection. Voxelized phantoms were 
created from reconstructed CT images with a voxel size of 3.9 x 3.9 x 4.1 mm
3
 for the 
adult and 2.3 x 2.3 x 2.0 mm
3
 for the pediatric phantom. Each voxel was classified as a 
material type based on the average attenuation value: air (-1000 to -930 HU), lung (-930 
to -200 HU), adipose tissue (-200 to -5 HU), water (-5 to -5 HU), soft tissue (+5 to +40 
HU), skeletal muscle (+40 to + 400 HU), and cortical bone (> +400 HU) [84]. The 
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National Institute of Standards and Technology (NIST) database was used to characterize 
the properties of the material within each voxel based on interactions between x-ray 
photons and the voxelized phantom [90]. Dose was calculated by summing the energy 
deposited in each voxel over the duration of scanning and dividing by the mass of the 
voxel. 
 
9.2.5 Comparison of MC simulation results to MOSFET measurements 
A conversion factor was used to convert simulated MC results into voltage values 
to compare to MOSFET measurements. The conversion factor was determined by 
comparing MOSFET measurements in a CTDI phantom with MC simulations of the 
same CTDI phantom. MC doses were converted to voltages by multiplying the MC to 
MOSFET conversion factor. By comparing MC to MOSFET, a ratio was obtained.  
Five measurements were averaged to obtain the voltage ratio (dose ratio) of 
MOSFET j for that set of measurements. The standard deviation of the ratio in the in-
field region was estimated by taking the average ratio of MOSFET voltage and voltage 
from the MC simulation. The error estimate of the ratio in an in-field location was 
calculated by averaging the estimated error,  
√𝑠1
2(𝑉MOSFET,𝑗 𝑉MC,𝑗⁄ ) ,     (9-3) 
where s
2
 is the variance of the voltage ratio between the voltage of all in-field MOSFETs 
(VMOSFET) and the voltage of the MC (VMC) for that particular protocol.  
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9.3 Results 
A total of 26 scan protocols were evaluated and a list of measurement and 
simulation results are reported (Table 9.1). The average ratio of MOSFET dose and MC 
dose for the in-field region was close to 1 (range, 0.93 to 1.09; mean ± standard 
deviation, 0.99 ± 0.04) (Table 9.2).  
For all scans except the female prospective ECG-triggered axial scans, the 
majority of the values for the standard deviation and the average estimated error closely 
matched each other, indicating that most variation is due to the MOSFET measurement 
error and that the scans were modeled accurately. 
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Table 9.1: A description of 26 scans performed on an adult (male and female) and 
pediatric phantom for different scan modes (helical, electrocardiogram (ECG)-gated 
helical, and non-gated axial) at varying tube potentials and scan lengths with scanner 
reported volumetric CT dose index (CTDIvol) values.  
Scan 
Series 
Phantom Scan Region Scan Mode Peak 
Tube 
Potential 
(kVp) 
CTDIvol 
per scan 
(mGy) 
Scan 
Length 
(cm) 
1 Female Chest Helical 120 27 302.4 
2 Male Chest Helical 120 27 302.4 
3 Male Chest Helical 100 17.8 303.0 
4 Male Abdomen Helical 120 27.0 420.8 
5 Male Brain Helical 120 62.1 160.0 
6 Male Brain Helical 100 42.0 160.0 
7 Female Chest Helical 100 17.8 302.4 
8 Female abdomen Helical 120 27.0 421.2 
9 Female Cardiac Non-gated 120 29.5 140.4 
10 Female Cardiac Non-gated 100 18.4 140.4 
11 Female Cardiac Non-gated 80 8.2 140.4 
12 Female Cardiac Non-gated 100 10.7 140.4 
13 Female Cardiac ECG-gated 120 51.3 140.4 
14 Female Cardiac ECG-gated 100 30.7 140.4 
15 Female cardiac ECG-gated  120 51.3 140.4 
16 Male cardiac Non-gated 120 29.5 140.4 
17 Male Cardiac Non-gated 100 18.4 140.4 
18 Male Cardiac Non-gated 80 8.2 140.4 
19 Male Cardiac Non-gated 100 10.7 140.4 
20 Male Cardiac ECG-gated 120 51.3 140.4 
21 Male Cardiac ECG-gated 100 30.7 140.4 
22 male Cardiac ECG-gated  120 51.3 140.4 
23 Infant Brain Helical 100 24.9 120.0 
24 Infant Chest Helical 100 17.6 180.0 
25 Infant Chest Helical 100 17.6 180.0 
26 infant Chest abdomen 
pelvis 
Helical 100 9.3 315.0 
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Table 9.2: Summary of results including the average ratio of metal-oxide semiconductor field effect transistors (MOSFETs) 
and voltage from Monte Carlo (MC) simulated in the in-field region with standard deviation and estimated error calculated for 
each adult (male and female) and pediatric phantom  
Scan 
Number 
Phantom Number of in-
field MOSFETs 
<VMOSFET/VMC> Standard Deviation 
of the in-field ratio 
Estimated Error for 
the ratio in the in-
field region 
1 female 29 1.00 0.05 0.05 
2 male 26 1.00 0.04 0.05 
3 male 26 0.98 0.05 0.05 
4 male 25 1.00 0.04 0.05 
5 male 6 1.00 0.03 0.05 
6 male 6 0.98 0.07 0.05 
7 female 25 1.00 0.06 0.05 
8 female 29 0.96 0.04 0.05 
9 female 15 1.05 0.09 0.06 
10 female 15 1.04 0.10 0.06 
11 female 15 1.09 0.11 0.07 
12 female 15 1.05 0.10 0.06 
13 female 17 1.00 0.06 0.05 
14 female 17 0.98 0.06 0.05 
15 female 17 0.99 0.06 0.05 
16 male 12 1.00 0.03 0.05 
17 male 12 0.98 0.07 0.05 
18 male 12 0.98 0.07 0.06 
19 male 12 0.97 0.07 0.06 
20 male 14 0.96 0.06 0.05 
21 male 14 0.93 0.06 0.05 
22 male 14 0.94 0.06 0.05 
23 infant 7 0.98 0.05 0.05 
24 infant 31 0.93 0.04 0.05 
25 infant 33 0.93 0.06 0.05 
26 infant 41 0.95 0.06 0.05 
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VMOSFET/VMC = the ratio of dose measured from MOSFETs and dose simulated from Monte Carlo methods. 
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9.4 Discussion 
Radiation dose estimates using a MC method were strongly correlated with 
MOSFET measurements in a physical adult (male and female) and infant 
anthropomorphic phantoms for a wide range of scan protocols performed on a 256-slice 
CT scanner. MC simulation results were converted into voltage values for comparison to 
MOSFET measurements.  
The standard deviation of the ratio in the in-field region, determined by estimation 
from the measurement results of that particular scan, indicated that if the estimated 
standard deviation was close to the estimated error then modeling of the scan was 
accurate. Although the average ratio of MC dose and MOSFET dose in the directly 
irradiated region was close to 1, MC results started to deviate from MOSFET 
measurements as distance from the edge of the direct radiation field increased which is 
consistent with previous studies [91]. 
Significant deviations occurred with female prospective ECG-triggered axial 
scans, male retrospective ECG-gated helical scans, and infant chest/abdomen non-gated 
helical scans. These deviations could be attributed to both measurement and calibration 
errors. The average ratio between MOSFET and MC results for female axial cardiac 
scans were about 5-10% higher than the expected value of 1.00. The standard deviation 
ratio was higher than the estimated error for these scans possibly indicating a problem 
with the MC simulations. The source of the error is not immediately known since we 
would expect to have a similar effect in the other simulations which is not the case. The 
average ratio was lower than expected for the male helical cardiac scans. This could be 
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attributed to systematically low readings from one of the MOSFETS (leading to ratios 
below 0.9) used in all male cardiac scans but none of the other scans. For infant scans, 
average ratios were correct in the head and shoulder region but lower than expected in the 
chest/abdomen region. The source of this error requires further investigation. 
 
9.5 Conclusion 
In conclusion, the MC tool was tested for medical X-ray dose calculation against 
MOSFET measurements for a wide range of scan protocols for both adult men and 
women, and an infant. The test showed that the MC tool provides very accurate dose 
values in most cases.  
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CHAPTER X 
OBESE PATIENT STUDY 
A Pilot of Study of Patient-Specific Cardiovascular MDCT Dose Maps and Their 
Utility in Estimating Organ and Effective Doses in Obese Patients 
 
 
10.1 Introduction 
Recent reports of increased utilization of ionizing radiation-based medical imaging, 
particularly computed tomography (CT) [92], and concern about the associated potential 
health risks [93] have created a demand for improved estimation, reporting, and recording 
of radiation dose from CT. The effective dose (E), in units of millisieverts (mSv), is a 
dose descriptor reflecting the relative biological sensitivity of irradiated organs and 
tissues. E has traditionally been computed for CT radiological procedures using 
sophisticated Monte Carlo (MC) methods to simulate the transport of ionizing radiation 
through the body [35, 49, 72, 94] . Pretabulated Monte Carlo (MC) simulation data used 
by CT dose estimate tools such as the ImPACT patient dosimetry calculator, CT-Dose, 
and CT Expo are based on a 70-kg reference phantom [95] intended to represent the 
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average-sized American adult [96]. Therefore, these tools do not account for overweight 
or obese patients [96-99]. The mathematical reference phantom used for MC simulations 
also includes organs that are characterized as simple geometric shapes: cylinders, 
ellipsoids, and cones [95]. Therefore, standard MC simulation methods for organ dose 
estimation in the adult population are largely patient generic because individual body 
habitus and organ sizes are not accounted for in the dosimetry phantom [100].  
In the clinical setting, a more practical method for estimating E from a CT 
procedure uses scanner-provided dose-length product (DLP) values and published DLP 
conversion factors [101] for different body regions. DLP-derived E estimates, however, 
are not patient-size specific. DLP values are computed as the scanner-reported volume 
CT dose index (CTDIvol) multiplied by irradiated scan length. CTDIvol is obtained from a 
32-cm (adult body) or 16-cm (adult head, pediatric) cylindrical polymethyl methacrylate 
(PMMA) phantom and therefore provides only an indication of the amount of ionizing 
energy imparted to a phantom during a specific CT scan. Furthermore, standard 
mathematical phantoms used to generate the DLP conversion factors for adults ignore 
differences in sex, body habitus, and scanner type [72]. DLP-derived E estimates are least 
accurate for patients smaller (thin adults) or larger (overweight or obese adults) than the 
standard 32-cm phantom [49], highlighting the need for more patient-size specific dose 
estimates in these groups.  
Patient-specific 3D anatomical dose maps have the potential to overcome some of 
the limitations of standard methods for estimating E, particularly DLP-based estimations. 
Dose maps are generated by performing MC simulations on virtual phantoms created 
from a patient’s own CT data rather than a standard adult reference phantom. 
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The primary aim of this study was to create patient-specific dose maps for 
estimating organ and effective doses (EDoseMap) and compare these doses to those 
determined from standard DLP conversion methods (EDLP) in obese adults undergoing 
cardiovascular CT.  
 
10.2 Materials and Methods 
This retrospective study was approved by our institutional review board with waiver of 
informed consent and was compliant with the Health Insurance Portability and 
Accountability Act. Patients were randomly selected from a database of cardiovascular 
CT patients to represent obese men and women over a range of body sizes. Patients with 
anatomy extending beyond the scanner’s field of view were excluded from the study. 
Twenty-one obese patients (24-73 years, 10 women) with body mass index (BMI) 
ranging from 30 to 61 kg/m
2
 were imaged for evaluation of the thoracic aorta (n = 9), 
pulmonary veins (n = 9), or coronary arteries (n = 3).  
 
10.2.1 CT Imaging 
For quality assurance of the CT scanner, CTDI is measured annually by a qualified 
medical physicist using two acrylic, cylindrical phantoms: head phantom with 16 cm 
diameter and body phantom with 32 cm diameter, both with a length of 14 cm. The 
measured CTDI is compared to the vendor-supplied CTDI displayed on the scanner 
console; the difference must be within a tolerance limit of +/-15%.  
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 Data were acquired from patients after contrast injection (75-90 mL of 370 
mgI/mL contrast agent [Ultravist 370, Berlex, Montville, NJ]) using prospectively 
electrocardiogram (ECG)-triggered axial techniques with a gantry rotation time of 280 
ms on a 256-slice CT scanner (iCT, Philips Medical Systems, Cleveland, Ohio). Tube 
potential (100 or 120 kVp) and tube current-time product (80–295 mAs) were selected 
depending on patient size and imaging target (thoracic aorta, pulmonary veins, or 
coronary arteries). Data acquisition was prescribed at 75% of the RR interval for 
evaluation of the thoracic aorta and at 40% of the RR interval for evaluation of 
pulmonary veins. Images used for dose map creation were reconstructed with a full 500-
mm field of view. CTDIvol and DLP values, provided by the scanner and based on 
CTDIvol and scan length, were recorded.  
 
10.2.2 SSDE Determination 
As previously described (in Chapter 4), AAPM described the use of size-based 
conversion factors to determine SSDE from the scanner-reported CTDIvol [2]. SSDE was 
calculated for this study. 
 
10.2.3 Dose Map Creation 
Patient-specific dose maps displaying pixels with values representing the 
absorbed dose of corresponding tissue voxels were created from patient datasets using a 
previously validated MC simulation tool (Diagnostic Photon Simulation [DiPhoS], 
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Philips Research, Eindhoven, Netherlands). The MC simulations were conducted on a 
computer (Linux) cluster with 20 CPUs and modeled the entire imaging chain including 
the generation of x-rays, modification of x-rays through processes such as beam shaping 
and filtering, and the propagation of x-ray photons through the body. Scanner 
configuration and acquisition parameters were extracted as input for the MC tool.  
A patient-specific virtual phantom was created by voxelizing each patient’s image 
set. Each voxel was classified as one of six material types based on fixed Hounsfield unit 
(HU) threshold values: air (–1000 HU), lung (–930 HU), adipose tissue (–200 HU), soft 
tissue (+5 HU), skeletal muscle (+40 HU), and cortical bone (+400 HU). Stoichiometry 
was used to compute the mass attenuation coefficient for each material type and the 
applied x-ray spectrum. Each voxel was assigned a mass density estimate based on its 
measured HU value and calculated mass attenuation coefficient [84]. The mass of tissue 
within a given voxel was then computed from the mass density and voxel size. A specific 
organ’s mass was determined by integrating over all voxels contained within the organ.  
A large number of photon histories (50x10
6
 photons per view with 1000 views) 
were simulated per scan to obtain precise estimates [85]. The energy deposited in each 
voxel was computed and tallied in a corresponding voxelized grid [85]. The energy 
imparted (Joules) was divided by the mass (kg) of the irradiated tissue to determine the 
CTDIvol-normalized absorbed dose in each voxel. Normalized absorbed dose was 
multiplied by the scanner-provided CTDIvol (mGy) to obtain absorbed dose (mGy).  
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10.2.4 Organ Segmentation 
Radiosensitive organs in the scan range were manually segmented from dose maps by 
two consulting observers (C.T., K.Y.) to determine the average absorbed dose for each 
organ. Segmented organs included skin, lungs, breasts, stomach, liver, and esophagus. 
For organs partially exposed during a scan (e.g. stomach and liver) [81], organ dose was 
based on direct exposure to the portion of the organ within the scan range and indirect 
exposure from the tail of the dose profile to the portion of the organ outside the scan 
range.  
 
10.2.5 Effective Dose Calculation 
E was determined using the clinically accepted standard conversion factor (k) for 
the chest, 0.014 mSv × mGy
-1
 × cm
-1
 [101]. This conversion factor was derived from 
organ weighting factors defined by the International Commission on Radiological 
Protection in publication 60 (ICRP 60) [102], multiplying k by the scanner-provided DLP 
then yielded: EDLP = DLP × k. For comparison, EDoseMap 60 was determined by multiplying 
individual organ doses (OD) measured from dose maps by the appropriate tissue-
weighting factor (w60) from ICRP 60 and summing over all organs:  
EDoseMap 60 = ΣODi × w60i.     (10-4) 
E values were also calculated on the basis of updated ICRP weighting factors 
from publication 103 (w103) [103]. EDLP 103 was determined by multiplying the scanner 
provided DLP by tube potential-specific conversion factors for the chest (0.0145 mSv × 
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mGy
-1
 × cm
-1
 at 120 kVp and 0.0144 mSv × mGy
-1
 × cm
-1
 at 100 kVp) proposed by Deak 
et al [72] using ICRP 103 tissue weighting factors. EDosemap 103 was determined by 
multiplying dose map measured organ doses by the appropriate tissue-weighting factor 
(w103) from ICRP 103 and summing over all organs:  
EDoseMap 103 = ΣODi × w103i.    (10-5) 
 
10.2.6 Statistical Analysis  
Mean SSDE and CTDIvol values were compared using a paired t-test. A 
significance level of 0.05 was applied. A linear regression model tested the difference 
between SSDE and CTDIvol as a function of BMI.  
A Pearson correlation coefficient was estimated to assess the linear correlation of 
CTDI-normalized absorbed dose for lung and breast tissues. A Bland-Altman plot was 
constructed to compare dose map-derived organ doses (mGy) using ICRP 103 tissue 
weighting factors to SSDEs.  
A paired t-test was used to assess differences in EDLP 60 and EDoseMap 60. A 
significance level of 0.05 was applied. A simple linear regression model, with the 
difference between EDLP 60 and EDoseMap 60 as the dependent variable and BMI as the 
predictor, was used to assess the influence of BMI on the difference between these two 
estimation methods. The analyses were repeated to assess the difference between E 
values determined from EDLP 103 and EDoseMap103.  
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10.3 Results 
Dose maps were created and used to determine organ and effective doses in 21 patients 
(Fig 10.1, Table 10.1). For each patient, dose map creation required about 3 hours using 
the computer cluster and segmentation of the organs required about 10 hours using a 
manual approach. 
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Table 10.1 Process of effective dose estimation for dose map method and dose-length product (DLP) conversion 
method in a sample patient 
Dose Map Method  
Organs Absorbed 
Dose 
(mGy) 
Weighting 
Factor ICRP 60 
  
Equivalent 
Dose ICRP 60 
(mSv) 
E DoseMap 60 
(mSv) 
Weighting 
Factor ICRP 103 
 
Equivalent Dose 
ICRP 103 (mSv) 
E DoseMap 103 
(mSv) 
 
Lung 23.9 0.12 2.9 8.1 0.12 2.9 9.3 
Breast 23.6 0.05 1.2 0.12 2.8 
Stomach 12.5 0.12 1.5 0.12 1.5 
Liver 27.0 0.05 1.4 0.04 1.1 
DLP Conversion Method 
DLP  
(mGy x cm) 
k for chest ICRP 60 
(mSv x mGy
-1
 x cm
-1
) 
E DLP 60 (mSv) k for chest,120 kVp ICRP 103 
(mSv x mGy
-1
 x cm
-1
)  
 E DLP 103  
(mSv) 
1018 0.014 14.3 0.0145 14.8 
ICRP 60 = International Commission on Radiological Protection publication 6019  
EDoseMap 60 = Effective dose determined from dose maps using ICRP 60 weighting factors 
ICRP 103 = International Commission on Radiological Protection publication 103 20 
EDoseMap 103 = Effective dose determined from dose maps using ICRP 103 weighting factors 
k ICRP 60 = Conversion factor based on weighting factors from ICRP 60
11  
EDLP 60 = Effective dose determined from DLP conversion method using k ICRP 60 
k ICRP 103 = Conversion factor based on ICRP 103 weighting factors
3  
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Figure 10.1: An example of an axial CT attenuation image (A), the corresponding 
dose map displaying volume CT dose index (CTDIvol)-normalized absorbed dose 
values (mGy/mGy) (B), and dose map with lung segmentation indicated by black 
contours (C) for a male patient with a body mass index of 45 kg/m2. The patient 
was imaged with a prospective electrocardiogram-triggered axial technique at a 
tube potential of 120 kV for evaluation of the thoracic aorta. The dose map shows 
nonuniformity (more dose accumulation on the patient’s left side) because at this 
slice position, the x-ray tube was positioned such that x-rays entered that portion 
of the patient twice during the 400 degree rotation required for data acquisition. 
 
The absolute difference between SSDE and CTDIvol values was < 6.4 mGy (Fig 
10.2). The mean (± SD) SSDE was 20.1 (± 9.0), whereas the mean CTDIvol was 20.8 (± 
9.4). This difference was not significant (95% CI: –1.84, 0.37; P = .180). The Pearson 
correlation coefficient (r = 0.966) indicated a strong relationship between SSDE and 
CTDIvol, which was expected since CTDIvol was factored into the calculation. A linear 
regression characterized the absolute difference between SSDE and CTDIvol as a function 
of BMI. The slope estimate was small and statistically insignificant (estimate = 0.003; 
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95% CI: –0.12, 0.12; P = .965), indicating that the absolute difference between SSDE and 
CTDIvol was not affected by patient size.  
 
 
Figure 10.2: Size-specific dose estimate (SSDE) versus volume computed tomography 
dose index (CTDIvol) with a line of symmetry showing the equivalency of these values 
 
The observed variability of breast and lung CTDI-normalized absorbed doses 
among patients (Fig 10.3) was notable, as standard methods of dose estimation do not 
account for differences in organ dose. Normalized lung and breast doses varied by a 
A 
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factor of approximately 6, from 0.18 to 0.99 for the lung (between-patient SD, 0.28) and 
from 0.16 to 0.99 for the breast (between-patient SD, 0.26), indicating the dose maps’ 
sensitivity to differences in organ size and tissue composition across patients. Patients’ 
lung and breast normalized doses were correlated (r = 0.88; P < .001). 
 
Figure 10.3: Volume computed tomography dose index (CTDIvol)-normalized absorbed 
dose for lung and breast tissue plotted by body mass index demonstrates the variability in 
these organ doses with patient size 
 
Comparison of dose map-derived breast and lung doses to SSDEs indicated that SSDEs 
were higher than the breast dose in 16 patients and higher than the lung dose in all 21 
patients (Fig 10.4). The mean difference between SSDE and lung dose values was 9.10 
mGy (95% CI: 5.88, 12.31; P < .001). The mean difference between SSDE and breast 
dose values was 4.07 mGy (95% CI: 0.08, 8.06; P = .046). 
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Figure 10.4: Bland-Altman plot showing lack of agreement between lung and breast 
absorbed doses derived from dose maps versus size-specific dose estimates (SSDEs). 
SSDEs tended to be higher 
 
The DLP method provided higher doses compared to the dose map method (Fig 
10.5). Mean EDoseMap 60 was 3.4 (± 2.3) mSv, whereas mean EDLP 60 was 5.7 (± 3.3) mSv 
(difference = 2.3 mSv; 95% CI: 1.2, 3.4; P < .001). A linear regression model did not 
suggest that this difference varies with BMI (slope estimate = 0.02; 95% CI: –0.15, 0.19; 
P = .825). The mean difference in EDLP and EDoseMap decreased slightly when estimates 
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were based on ICRP 103 but was still differed from 0: mean EDoseMap 103 was 4.0 (±2.7) 
mSv, whereas mean EDLP 103 was 5.9 (±3.5) mSv (difference = 1.93 mSv; 95% Cl: 0.78-
3.09; p=0.002). Again, a linear regression model did not suggest this difference varies 
with BMI (slope estimate = 0.01; 95% Cl:-0.16, 0.18; P = 0.911).  
 
 
Figure 10.5: A box and whisker plot showing effective doses (EDLP 60, EDLP 103) estimated 
from the dose-length product using the standard conversion factor derived from the 
International Council on Radiation Protection [ICRP] publication 60 and updated ICRP 
publication 103 tended to be higher than those derived from dose maps (EDoseMap 60, 
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EDoseMap 103) using ICRP 60 and 103 weighting factors. The bottom and top of each box 
represent the 1
st
 and 3
rd
 quartiles, while the bold line represents the median. The whiskers 
extend to the most extreme data point which is no more than 1.5 times the interquartile 
range from the box and any points outside the whiskers’ range (outliers) are represented 
by small circles 
 
10.4 Discussion 
E provides a means to express the amount of radiation a population receives from 
a specific CT procedure and compare that amount to radiation from other sources, both 
medical and non-medical. Our results showed that the standard DLP conversion method 
yielded higher dose estimates compared to the dose map method for estimating E in a 
population of obese adults. Although still different from 0, the mean dose difference 
decreased when updated ICRP 103 tissue weighting factors were used reflecting 
primarily an increase in dose map derived doses due to an increase in the tissue weighting 
factor for the breast from 0.05 to 0.12. Overestimation of E with the DLP method occurs 
in part because obese patients are larger than the 32-cm diameter phantom used to 
determine scanner-provided CTDIvol and DLP values and larger than the 70-kg reference 
phantom used to determine body region-specific conversion factors. Adjustments should, 
therefore, be applied to dose estimations for patient groups that deviate from these 
standard sizes.  
Other groups have highlighted the dependency of DLP to E conversion factors on 
patient size. Deak et al derived sex-, age-, and tube potential- specific conversion factors 
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for the chest using Monte Carlo methods to simulate scanning of mathematical phantoms 
representing children and non-obese adults on a 64-slice CT scanner. For a non-obese 
adult, the standard conversion factors for the chest ranged between 0.0135 and 0.0138 
mSv × mGy
-1
 × cm
-1
 based on tissue- weighting factors from ICRP 60 and 0.0144 and 
0.0147 mSv × mGy
-1
 × cm
-1
 based on factors from ICRP 103, close to the current single 
reference value of 0.014 mSv × mGy
-1
 × cm
-1
. However, the appropriate conversion 
factor for the chest increased with decreasing patient size with values for newborns based 
on tissue-weighting factors from ICRP 60 to 103 ranging from 0.0634 to 0.0823 mSv × 
mGy
-1
 × cm
-1
. Following the same logic, the appropriate conversion factor for the chest 
should decrease with increasing patient size. Using whole body computational phantoms 
created from clinical CT images of normal weight (n=3) and obese (n=3) adults, Li et al 
[104] demonstrated k factors used to estimate E for the chest should be reduced for obese 
compared to non-obese men and women and further noted that the appropriate conversion 
coefficients cannot be predicted using body diameter alone. Einstein et al further 
demonstrated the dependency of DLP to E conversion factors on the specific scanner 
technology and specific region-of-interest (e.g. cardiac versus chest) (19). Dose maps 
inherently account for differences in patient and organ sizes, scanner technology and 
irradiated organs and tissues.  
The AAPM attempted to capture the dependency of patient dose on patient size 
by developing a patient size-based modification to the scanner-provided CTDIvol [2]. The 
report provided correction factors based on a patient’s estimated effective diameter [2]. 
Our patients had an average effective diameter of 36.5 cm, corresponding to an average 
normalized dose coefficient close to 1. This correction factor yielded SSDEs that were 
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not significantly different from original CTDIvol values, suggesting that improved 
dosimetry accuracy may not be realized for obese patients using this approach, perhaps 
because organ size and tissue differences are not taken into account. Although 
computation of SSDEs did not seem to account for size differences in our patients for 
thoracic CT, SSDE has been shown to account for patient size well in dose estimation for 
abdominopelvic CT [105]. 
MC methods using well-established cylindrical and physical phantoms, 
mathematical models (stylized) [68, 72, 94, 106-109], voxel models (tomographic) [67, 
70, 71, 73, 81, 95, 100, 108, 110], and hybrid models [49, 51, 111, 112] have been used 
to estimate CT dose. However, mathematical models do not consider variabilities in 
patient size and organ size and shape; they contain fixed geometric anatomic shapes 
characterized by equations. The positions of organs in mathematical models can also be 
unrealistic [107] and contribute to overestimation or underestimation of doses. 
Inaccuracies in model dose estimates also stem from modeling body composition. Organ 
doses in adolescent patients assessed using stylized hermaphrodite phantoms and hybrid 
phantoms differed by up to 2-fold; hybrid phantoms permitted more accurate modeling of 
body composition [49].  
Dose estimation is also possible from voxelized models of CT images [70, 71, 73, 
78, 113]. Schmidt and Kalender [73] developed a MC method that yielded doses from 
voxelized CT images of anthropomorphic phantoms that differed < 5% from CTDI 
results obtained with a standard MC-based program (EGS4) and published organ dose 
conversion factors. DeMarco et al [71] showed good agreement between dose estimated 
from MC methods applied to voxelized images of cylindrical body and anthropomorphic 
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phantoms compared with dose determined from physical phantoms using metal-oxide 
semiconductor field effect transistors (MOSFETs). Deak et al [70] found that calculated 
dose values from 3D dose distributions of voxelized phantom images were within 10% of 
phantom measurements (Alderson-Rando and cylindrical CTDI) using 
thermoluminescent dosimeters (TLDs). In our study, we created dose maps by voxelizing 
each patient’s CT images, providing a more patient-specific approach compared to 
previous studies.  
Individual organ doses also contribute to E and can be used to assess radiation 
risk from diagnostic imaging procedures. Unlike DLP-derived dose estimates, MC 
simulation permits organ dose estimation. However, differences between models and 
actual patients, as well as variations in scanner geometries and X-ray beam spectra, 
contribute to inaccuracies in organ dose estimation [74, 78]. Our approach is sensitive to 
these differences; we demonstrated variability in normalized absorbed doses to highly 
radiosensitive organs (breast and lung) across patients.  
Our method of organ and E estimation did have limitations. A 400-HU threshold 
was used to classify highly attenuating tissue (including contrast-enhanced blood) as 
bone, and subsequent MC simulations and stoichiometry assumptions were based on this 
tissue classification. The significance of this on dose estimation is currently under 
investigation. Another limitation was manual organ segmentation. Automatic organ 
segmentation would reduce data analysis time and possibly produce more accurate organ 
doses through objective differentiation of organs and tissues based on a tissue 
classification rubric. Additionally, the method used to calculate equivalent dose to 
partially irradiated organs was limited by the need to assume a total length for the organ. 
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Also, a larger patient population could strengthen our conclusion; however, including 
additional patients is difficult because of the intensive MC calculations currently required 
to create patient-specific dose maps. Finally, only one clinical scanner was studied.  
10.5 Conclusion 
In conclusion, anatomic dose maps created from patient CT images enable more 
scanner- and patient-size specific estimation of organ and E and provide lower dose 
estimates for obese patients undergoing cardiovascular CT procedures than standard E 
estimation methods based on the scanner-provided DLP. Considering patient size, organ 
size, and the composition of irradiated tissue could lead to better metrics for CT dose 
management, particularly for obese patients 
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CHAPTER XI 
CONTRAST STUDY 
A Preliminary Study using Patient-specific Dose Maps to Quantify CT Radiation 
Dose in the Presence of Iodinated Contrast 
 
 
11.1 Introduction 
Administration of iodinated contrast media (CM) is a critical component of computed 
tomography angiography (CTA) because enhancement of the vessels allows angiographic 
visualization of the vessel luminal detail. The local x-ray absorption coefficient of a 
tissue or material is dependent on its electron density and effective atomic number (Z). 
Iodine (Z=53) is the optimal choice for water-soluble imaging agents because it forms 
soluble compounds with low toxicity and its high atomic number allows it to absorbs 
more x-rays, and thus, appears brighter on the CT image than soft tissue [13, 114].  
Iodine can accumulate at different concentrations when injected in the body. The 
quantity of iodine accumulated in the great vessels and organs at the time of scan as well 
as organ shape, volume, and position within the body [3, 4] determines x-ray absorption 
during the CT scan. Unlike traditional dose descriptors (volume CT dose index [CTDIvol], 
dose-length product [DLP]) , patient-specific dose maps generated from patient images 
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using Monte Carlo simulations are sensitive to the presence of iodinated CM during a CT 
scan [3, 4]. Patient-specific dose maps display pixels with values representing the 
absorbed dose of corresponding tissue voxels.  
The aim of this study was to determine if patient-specific dose maps demonstrate 
differences in absorbed dose to organs in the chest, abdomen, and pelvis before and after 
administration of iodinated CM. The methods used to quantify radiation dose in the 
presence of iodinated contrast are discussed along with preliminary results.  
 
11.2 Materials and Methods 
This study was approved by our institutional review board with waiver of informed 
consent and was compliant with the Health Insurance Portability and Accountability Act. 
Patients were randomly selected from a database of CT patients to represent men and 
women of different ages with a range of body sizes. The chest, abdomen, and pelvis of 
ten patients (37-86 years, 4 women) with body mass index (BMI) ranging from 24-38 
kg/m
2
 were imaged for evaluation before or after endovascular stent graft repair.   
 
11.2.1 CT Imaging 
Patients were imaged with a non-gated helical technique during a non-contrast, arterial, 
and venous phase. Arterial phase scanning was triggered when peak attenuation was 
reached in the descending aorta just after the administration of 80 mL of 350 mgl/mL CM 
(Omnipaque 350, Berlex, Montville, NJ). CTDIvol and DLP values provided by the 
scanner were recorded. Identical scan parameters were chosen for non-contrast and 
arterial phase scanning for a given patient; the tube current-time product was lowered 
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during the venous phase. Images used for dose map creation were reconstructed with a 
full 500-mm field of view.  
 
11.2.2 Attenuation Measurements 
Average attenuation was measured by drawing a region of interest (ROI) on three 
consecutive CT slices for each patient in select organs (stomach, liver, pancreas, spleen, 
and kidneys) during each phase (non-contrast, arterial, and venous).  
 
11.2.3 Dose Map Creation 
Patient-specific dose maps were created from non-contrast and arterial phase patient 
datasets using a previously validated Monte Carlo simulation tool (Diagnostic Photon 
Simulation [DiPhos], Philips Research, Eindhoven, Netherlands). MC simulations 
modeled the entire imaging chain including the generation of x-rays, modification of x-
rays through processes such as beam shaping and filtering, and the propagation of x-rays 
photons through the body. 
A patient-specific virtual phantom was created by voxelizing each patient’s non-
contrast and arterial phase image sets. Each voxel was classified as one of 26 material 
types based on tube potential-specific, fixed Hounsfield Unit (HU) threshold values 
(Table 11.1). Stoichiometries and densities were modeled from chemistry and the 
appropriate International Commission on Radiation Units and Measurements (ICRU) 
body material recommendations. Although bone was included in the body material 
recommended, it was omitted from the tissue scheme because its tissue weighting factor 
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is negligible. The new tissue scheme includes blood/contrast mixtures from 100% blood 
to 20% contrast + 80% blood.  
Table 11.1: Material classification scheme for voxelizing patient images for each 
tube potential 
 
Material Type 
Attenuation Threshold 
at 100 kVp (HU) 
Attenuation Threshold 
at 120 kVp (HU) 
Air -1000 -1000 
Lung Tissue -930 -930 
Adipose Tissue -200 -200 
Water -5 -5 
Soft Tissue 5 5 
Blood (100%) 62 60 
Blood (99%) + Contrast media (CM) (1%) 137 125 
Blood (98%) + CM (2%) 282 251 
Blood (97%) + CM (3%)  427 377 
Blood (96%) + CM (4%) 571 502 
Blood (95%) + CM (5%) 715 627 
Blood (94%) + CM (6%) 860 753 
Blood (93% + CM (7%) 1005 879 
Blood (92%) + CM (8%) 1150 1005 
Blood (91%) + CM (9%) 1294 1130 
Blood (90%) + CM (10%) 1439 1256 
Blood (89%) + CM (11%) 1584 1381 
Blood (88%) + CM (12%) 1727 1506 
Blood (87%) + CM (13%) 1872 1632 
Blood (86%) + CM (14%) 2017 1758 
Blood (85%) + CM (15%) 2162 1884 
Blood (84%) + CM (16%) 2307 2010 
Blood (83) + CM (17%) 2451 2134 
Blood (82) + CM (18%) 2596 2260 
Blood (81) + CM (19%) 2741 2386 
Blood (80) + CM (20%) 2884 2511 
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Stoichiometry was used to compute the mass attenuation coefficient for each material 
type and the applied x-ray spectrum. Each voxel was assigned a mass density estimate 
based on its measured HU value and calculated mass attenuation coefficient [84]. The 
mass of tissue within a given voxel was then computed from the mass density and voxel 
size. A specific organ’s mass was determined by integrating over all voxels contained 
within the organ.  
For each virtual phantom, the paths of individual X-ray photons through the 
irradiated tissue were modeled with MC methods based on known physical interactions 
(Rayleigh scattering, Compton effect, photoelectric effect) [85]. A large number of 
photon histories (50x10
6
 photons per view with 1000 views) were simulated per scan to 
obtain precise estimates [85]. The energy deposited in each voxel was computed and 
tallied in a corresponding voxelized grid [85]. The energy imparted (Joules) was divided 
by the mass (kg) of the irradiated tissue to determine the CTDIvol-normalized absorbed 
dose in each voxel. Normalized absorbed dose was multiplied by the scanner-provided 
CTDIvol (mGy) to obtain absorbed dose (mGy).  
11.2.4 Organ Segmentation 
Radiosensitive organs in the scan range were manually segmented from dose maps by 
two consulting observers (CT, PS) to determine the average absorbed dose for each 
organ. Segmented organs included skin, lungs, breasts, stomach, liver, esophagus, 
kidneys, pancreas, and spleen.  
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11.2.5 Effective Dose Estimation 
Effective dose (E ) in the non-contrast and arterial phases were calculated on the 
basis of updated International Council on Radiological Protection (ICRP) weighting 
factors from publication 103 (w103) [103]. EDosemap 103 was determined by multiplying dose 
map-measured organ doses by the appropriate tissue-weighting factor (w103) from ICRP 
103 and summing over all organs:  
EDoseMap 103 = ΣODi × w103i.     (11-1) 
 
11.2.6 Statistical Analysis  
E values calculated from the dose map method were compared in the non-contrast and 
arterial phase using a paired t-test. The absorbed dose to seven select organs was also 
compared in the non-contrast and arterial phases using a paired t-test. A significance level 
of 0.05 was used for all comparisons. A simple linear regression model, with the 
difference in EDose Map 103 between the arterial and non-contrast phases as a function of 
BMI was used to assess the influence of BMI on the difference in estimated dose between 
these two phases.  
 
11.3 Preliminary Results 
Attenuation increased for all evaluated organs in the arterial phase. The mean 
increase in attenuation was 11 HU in the stomach (95% CI: 3, 20 HU; p=0.018), 6 HU in 
the liver (95% CI: 2, 11 HU; p=0.015), 34 HU in the pancreas (95% CI: 22, 46 HU; 
p<0.001), 45 HU in the spleen (95% CI: 25, 65 HU; p=0.001), and 61 in the kidneys 
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(95% CI: 40, 81 HU; p<0.001). A higher attenuation is observed in the venous (Fig 11.1). 
Compared to the non-contrast phase, the mean increase in attenuation was 25 HU in the 
stomach (95% Cl: 17, 34 HU; p<0.001), 25 HU in the liver (95% Cl: 18, 32 HU; 
p<0.001), 30 HU in the pancreas (95% Cl: 17, 44 HU p=0.001), 30 HU in the spleen 
(95% Cl: 22, 38 HU p<0.001), and 88 HU in the kidneys (95% Cl: 65, 112 HU; p<0.001) 
during the venous phase.  
 
 
Figure 11.1: Average attenuation values (Hounsfield Units) in selected organs during 
non-contrast, arterial, and venous phases. 
 
Out of five organs assessed (Table 11.2) only the kidneys and pancreas showed a 
significant difference in absorbed dose between non-contrast and the arterial phases: the 
dose absorbed by the kidneys (14.7 vs. 13.4 mGy; 95% CI for the difference: 0.36, 2.30; 
p=0.013) and pancreas (13.8 vs. 13.2 mGy; 95% CI for the difference: 0.17, 1.13; 
p=0.014) was significantly higher in the arterial phase. No significant correlation was 
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observed between the difference in absorbed dose from the non-contrast to arterial phase 
and patient BMI (Fig 11.2). 
Table 11.2: A comparison of mean absorbed dose for select organs in the non-
contrast and arterial phases. A significant difference in dose between phases was 
only observed for the kidneys and pancreas. 
 
 
Organ Absorbed dose 
for non-contrast 
phase (mGy) 
Absorbed dose 
for arterial 
phase (mGy) 
Difference 
between 
phases 
95% 
Confidence 
Interval 
P value 
Stomach 12.8 12.9 0.05 (-0.74, 0.84) 0.889 
Liver 14.1 14.3 0.18 (-0.18, 0.54) 0.285 
Kidneys 13.4 14.7 1.33 (0.36, 2.30) 0.013 
Pancreas 13.2 13.8 0.65 (0.17, 1.13) 0.014 
Spleen 15.8 17 1.24 (-0.39, 2.87) 0.119 
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Figure 11.2: The difference in absorbed dose from the dose map method (EDose Map 
103) between the arterial and non-contrast phases as a function of BMI (body mass 
index). The dotted line represents the dose difference that is equal to zero.   
 
EDoseMap103 was slightly higher during the arterial phase compared to the non-
contrast phase (11.3 vs. 11.2 mSv; 95% CI for the difference: -0.35, 0.69; p=0.475). The 
difference in EDoseMap103 between the non-contrast and arterial phases was not affected by 
patient size (slope: -0.01, p=0.862). (Fig 11.3) 
 
Figure 11.3: The difference in effective dose (E) between the arterial and non-
contrast phases estimated using the dose map method (EDoseMap 103) as a function of BMI 
(body mass index). The solid line (best fit line) represents the linear model of how the 
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difference in E between the two phases changes with BMI and the dotted line represents 
the dose difference that is equal to zero.  
 
11.4 Discussion 
Our results demonstrate that patient-specific dose maps can evaluate organ doses 
before and after administration of iodinated CM. E was marginally higher in the arterial 
phase compared to the non-contrast phase. This difference did not correlate with patient 
BMI.  
Only the absorbed dose for the kidneys and pancreas were significantly higher in 
the arterial phase compared to the non-contrast phase. Measured attenuation differences 
between the non-contrast and venous phases suggest we might expect to see an increase 
in organ dose for the kidneys, liver, and stomach in the venous phase.  
Amato et al [4] assessed the measured HU increase and the corresponding 
radiation dose increment in the organs of 40 patients who underwent CT before and after 
contrast administration during the venous phase. Results showed an average organ dose 
increase of 71% for kidneys, 41% for the thyroid, and 33% for the spleen and pancreas 
[4] which reflects the timing of the scan relative to CM injection. Iodinated CM was 
released 80 seconds after the start of contrast administration. The relationship between 
HU increment and radiation dose increase was derived from previous work where Monte 
Carlo (MC) methods were performed on an anthropomorphic phantom with iodinated 
organs [3]. Organs, characterized as ellipsoidal shapes were assumed for the geometrical 
input of the MC code.  
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Although, Hounsfield-based determination of radiation is simple and quick, the 
method only utilizes information from a region of interest in select organs. Dose maps 
assess the entire organ and account for organ size and shape as well as position within the 
body. Dose maps also account for the effect of nearby iodine filled vessels on organ dose. 
Our study did have limitations. The patient population was small because of the 
intensive MC calculations required to create patient-specific dose maps. Also, we only 
evaluated a single time point, shortly after contrast was injected; venous phase dose maps 
were not evaluated because of differences in applied radiation. In our comparison of 
absorbed dose between non-contrast and arterial phases, we did not account for 
differences in the starting position of the x-ray tube which certainly influenced dose 
along with the differences in the presence of contrast. Our results may also have been 
limited by manual organ segmentation. Automatic organ segmentation might provide 
more consistency in segmentation between phases for an individual. 
Future work should include creation and evaluation of arterial and venous phase 
dose maps with the same input parameters (e.g., x-ray tube starting angle and x-ray tube 
current) as the non-contrast phase. This should ensure that measured differences in dose 
are only the result of differences in the presence of contrast agent in the vessels and 
organs among scans. 
 
11.5 Conclusion 
Patient-specific dose maps may have an advantage over traditional dose 
descriptors (CTDIvol and DLP) because they account for the presence of contrast agent in 
the great vessels and organs during a CT exam. Dose maps evidenced increased dose 
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during arterial phase imaging of the adult chest, abdomen, and pelvis compared to non-
contrast phase imaging. 
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CHAPTER XII 
CONCLUSIONS 
 
 
The growth of CT over the last 15 years has led to improved patient outcomes for 
the diagnosis of a wide range of clinical indications [115]. Proper indication, appropriate 
protocols, and scanner technology have resulted in decreased radiation exposure for 
individual scans. However, providing accurate dose estimates from a CT exam is still a 
major concern for clinical researchers so a strong desire remains to quantify dose 
especially radiation exposure to radiosensitive organs. 
The aim of this research was to evaluate the utility of patient-specific dose maps 
for CT exams. Patient-specific dose maps offers to overcome the current limitations of 
inaccurate dose estimation with standard dose descriptors. Standard dose descriptors do 
not take in account patient specific anatomy which leads to inaccurate dose estimates. It 
was shown that estimating dose will lead to either to an over -or underestimation 
especially for patients who are smaller or larger than 32-cm Plexiglas phantom. Patient 
size, individual organ size, and body composition should be accounted for to help 
improve the accuracy of dose estimation methods.  
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Computational phantoms offer a more realistic approach than physical phantoms. 
Voxel phantoms use the patient’s own CT images to capture the anatomical and organ 
differences in patients by modeling complex attenuating volumes. MC methods provide a 
powerful computational tool that can be used to simulate ionizing radiation for dosimetry 
in computational phantoms using known probabilities of occurrence [using random 
sampling of probability density functions for each event] to model the system. Most 
importantly, MC methods are attractive because of the possibility to estimate physical 
parameters that are difficult or impossible to calculate using experimental measurements 
and physical phantoms. The benefits of using MC in radiation transport enables 
optimization of instrumentation design and estimation of absorbed dose distributions for 
diagnostic exams or radiation treatment [86]. 
Validation of a MC tool with an anthropomorphic phantom is a preferred 
approach because these phantoms allow direct dose assessment. Organ dose can be 
directly measured with either TLDs or MOSFETs. Although, TLDs and MOSFETs are 
both beneficial for direct dose assessment; the process can be costly and time-consuming. 
Chapter IX showed the validation of dose maps where MOSFETs proved to an excellent 
choice because of their high spatial resolution and immediate dose readouts. The 
accuracy of dose calculations were tested by using the MC (DiPhos) simulation tool 
performed on an anthropomorphic phantom compared to MOSFET dosimeters placed 
inside the phantom. Results showed radiation dose estimates from DiPhos were strongly 
correlated with MOSFETs measurements in a physical adult and infant anthropomorphic 
phantom for a range of CT protocols. However, the average ratio between MOSFET and 
MC results for female axial cardiac scans were about 5-10% higher than the expected 
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value of 1.00 which possibly indicates a problem with the MC simulations. The source of 
the error is not readily apparent especially when we would expect to see a similar effect 
in the other protocols. Also, the infant chest/abdomen scans had a lower average ratio 
than expected but were correct in the head and shoulder region. It is believed that these 
errors are called systemic errors and stem from modeling of the scanning procedure. 
Additional measurements are required to identify the specific source of these errors.  
E reflects the relative biological sensitivity of irradiated organs and tissues. It also 
allows comparison of the biological effect between specific CT exams. Computing EDLP 
provides a generic approach to estimating E and it is especially apparent for obese 
patients as shown in Chapter X. Dose maps derived from patient CT images yielded 
lower E estimates than the DLP conversion method. This overestimation of E with the 
DLP method occurred in obese patients who are larger than the 32-cm diameter phantom 
that is used to determine scanner-provided CTDIvol and DLP values and also larger than 
the standard 70 kg reference phantom that is used to determine body region-specific 
conversion factors. Adjustments have to be made to dose estimation methods to account 
for patient groups that deviate from standard sizes. The introduction of SSDE was an 
improvement because it provided correction factors based on the estimated effective 
diameter of a patient. However, results showed that SSDE was not significantly different 
from original CTDIvol values suggesting that the improved dose descriptor might not be 
an option for obese patients because organ size and tissue differences are not taken into 
account. It is evident that these dose descriptors are poor indicators of dose. Dose maps 
provide a more accurate approach by enabling more scanner- and patient-size specific 
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estimation of organ and effective doses which provided lower dose estimates for obese 
patients undergoing cardiovascular CT procedures.  
Following the results in Chapter X, a new method that accounted for the presence 
of contrast media was used to create patient-specific dose maps. Results in Chapter XI 
showed that dose maps can account for to the presence of contrast agent in the great 
vessels and organs during scanning. The presence of contrast was shown to yield a slight 
increase in effective dose in the arterial phase compared to the non-contrast phase in an 
adult, chest, abdomen, and pelvis protocol. This sensitivity to the presence of contrast 
agent gives patient-specific dose maps an additional advantage over standard dose 
descriptors [4].  
Overall, a couple of limitations hinder the clinical adoption of MC tools. One 
major limitation is the intensive computation required for MC methods to efficiently 
model a system. Another limitation is the statistical uncertainties in the estimates. One 
way to decrease the statistical uncertainty is to run MC simulations for a sufficiently long 
time to generate a large number of photon histories and use efficient variance reduction 
techniques [86].  
The work presented in this dissertation has raised a couple of interesting research 
questions that should be addressed in the future. Will on-site patient-specific dose maps 
be a viable clinical option? As previously mentioned, the heavy burden of MC 
calculations is a limitation. This question is of great interest because MC methods 
provide an accurate and realistic evaluation of dose assessment. Graphics processing 
units (GPUs) are highly parallel coprocessors which functions to decrease the 
computational demand [113]. A large number of datasets can be processed in parallel to 
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achieve high performance. One advantage of using multiple GPUs is the use of separate 
memory. One group developed a MC tool that provides on-site dose distributions using 
multiple GPUs [113]. Implementing multiple GPUs would enable on-site dose maps to be 
created from scout images. Obtaining faster dose maps would allow clinical scientists to 
use the information from dose maps to plan patient scanning. This provides a prominent 
solution to compensate for the intensive computations required to accurately model a CT 
system and patient.  
Will dose maps have a significant role in pediatric dose estimation? This 
dissertation focused only on adult CT dose estimation, but it would be interesting to see 
what type of benefits the patient-specific dose maps could potentially provide for the 
pediatric population. Accurately estimating dose for this group is extremely important 
especially since they have a greater organ radiosensitivity and a longer lifespan [116].   
In conclusion, this research has shown that patient-specific dose maps have the 
ability to characterize, estimate E, and organ dose to a patient, and also quantify radiation 
dose a patient receives from a contrast-enhanced CT exam. As more dose maps are 
created, the next step would entail creating a library of dose maps from other patients. 
Therefore, when a patient comes into the hospital to be scanned, the operator would find 
the best matched dose map (from the library) to the current patient. These options would 
allow dose maps to be used appropriately by adjusting the scan protocol without 
compromising image quality for patients of all sizes. Although initial results look 
promising, a larger patient population is necessary. Computation intensive MC is a 
limitation but incorporating multiples GPUs would allow faster computation of dose 
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maps to be created from scout images of patients making it a clinical option in the near 
future. 
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APPENDIX 1: Methods for CT Effective Dose Estimation in Adult and Pediatric 
Populations 
 
 
A1.1 Introduction 
Rising concerns about the risks of radiation exposure from computed tomography (CT) 
examinations (1) have motivated numerous federal agencies and accrediting bodies in the 
U.S. to suggest improvements in monitoring, recording and reporting of radiation dose on 
a patient level. The federal government requires accreditation of non-hospital facilities 
that provide medical imaging services to meet standards to participate in Medicare (2, 3). 
The US Food and Drug Administration (FDA) and American College of Radiology 
(ACR) assure these facilities are in compliance (2, 3). As the FDA monitors and informs 
CT manufacturers of their statutory duty to report adverse events related to CT scanning, 
they are also working with the International Commission on Radiological Protection 
(ICRP) to incorporate radiation protection principles into facility quality assurance. The 
International Atomic Energy Agency (IAEA), developed and initiated a Smartcard to 
track a patient’s cumulative radiation exposure for individual procedures (4).  
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CT scanner manufacturers currently provide measures of scanner radiation output 
for each CT scan performed. Since patient dose depends on both scanner output and 
patient size, the adjustment of the scanner reported output on the basis of patient size has 
been proposed (5).  
The stochastic risk from the radiation dose received is also patient-dependent and varies 
according to the distribution of dose to an individual’s radiosensitive organs and patient 
age. The dose descriptor most commonly used to communicate radiation risk from a 
specific CT protocol is the effective dose (E). However, current methods for estimating E 
are patient-generic and appropriate only for population-level dosimetry because these 
methods do not account for age or overall body size and individual organ doses. This 
paper aims to discuss current methods for estimating E and a novel, more patient-specific 
method that accounts for patient-size and the radio-sensitivity of irradiated organs.  
 
A1.2 Measurement of Radiation Output with Physical Phantoms 
Physical phantoms are used to measure the radiation output from a CT scan. The 
volume computed tomography dose index (CTDIvol) expressed in units of milligray 
(mGy) and the dose-length product (DLP) expressed in units of mGy x centimeter (cm) 
are determined for each CT scan based on scanning a cylindrical polymethyl 
methacrylate (PMMA) phantom. CTDIvol represents the average amount of radiation 
imparted to a defined volume (cross-section) of a CTDI phantom and provides a measure 
of scanner radiation output (6). CTDIvol values are obtained for different combinations of 
dose-impacting scan parameters (e.g., tube potential, tube current, gantry rotation time, 
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detector configuration, pitch, beam filter) by scanning either a standard 32-cm or 16-cm 
CTDI phantom. The results are used to fill lookup tables for adult body protocols (32-cm 
phantom), adult head protocols (16-cm phantom), and pediatric protocols (16-cm 
phantom). For a given protocol, the appropriate look-up table is referenced and the 
CTDIvol corresponding to the programmed scan parameters is displayed. CTDIvol values 
are not intended to quantify patient dose but rather provide radiation output for a given 
scan protocol.  
The DLP accounts for the scan length and represents the total amount of ionizing 
radiation imparted to a reference phantom during a single CT scan and is obtained by 
multiplying the CTDIvol and the irradiated scan length. Although the scan length is 
determined by a given patient’s anatomy, the DLP, like the CTDIvol, still describes 
radiation dose to a phantom, not a patient, and is not intended to quantify patient dose (6).  
The dose absorbed by standard CTDI phantoms is known to underestimate dose to 
patients smaller than the phantoms and overestimate dose to patients larger than the 
phantoms. Absorbed dose from standard CTDI phantoms leads to 40-70% 
underestimation of dose for smaller adults and pediatric patients (7-9) whose bodies are 
smaller than the phantoms and provide less insulating tissue to shield highly 
radiosensitive organs from x-rays (7, 8). Brady and Kaufman observed that CTDIvol 
values from a 32-cm diameter phantom was a good surrogate for absorbed dose for 
patients weighing 113 kg but would lead to 29-66% underestimation of dose in patients 
weighing between 36 and 100 kg (7). Kalendar et al predicted dose would be 
overestimated for larger patients by CTDIvol values measured with a 32-cm diameter 
phantom (10).  
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A dose quantity was proposed by the American Association of Physicists in 
Medicine (AAPM) that adjusts the scanner-reported CTDIvol according to patient-size. 
The AAPM suggests multiplying size-based correction factors determined from lateral 
(LAT) and anterior-posterior (AP) measurements from patient images with the CTDIvol to 
calculate a size-specific dose estimate (SSDE) expressed in units of mGy (5). The SSDE 
then effectively provides information about the amount of radiation absorbed by a cross-
section of a reference phantom similar in size to a given patient. 
 
A1.3 Simulation of Radiation Dose in Computational Phantoms 
Monte Carlo (MC) methods simulate the transport of ionizing radiation through the body 
and the absorption of radiation energy during a variety of situations ranging from space 
travel to medical imaging by modeling every step in the radiation exposure process. 
Monte Carlo methods are applied to computational phantoms and used to simulate the 
radiation dose a patient would theoretically receive from a CT scan. The entire imaging 
chain is modeled including the generation of x-rays, modification of x-rays through 
processes such as beam shaping and filtering, and the propagation of x-ray photons 
through the body. Monte Carlo code incorporates Poisson statistics to track individual x-
ray photon histories. Random distances which a photon travels between interactions such 
as from a source through a medium (e.g., skin) to the detector are generated (11, 12). The 
random interactions of the photons are assigned probability functions of the mass 
attenuation coefficients (13), and used to generate a statistically large number of particle 
histories (11, 12). This makes it possible to predict properties of the radiation field such 
as the particle fluence, energy deposition, and energy spectrum at particular points (11, 
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12). The absorption of radiation energy within the body can be estimated but typically 
only reflects direct primary exposure of organs to x-rays from a CT scanner. Monte Carlo 
simulations have been validated against actual measurement of organ doses during 
scanning of physical phantoms (CTDI, anthropomorphic, and computational) (13-19). 
Monte Carlo methods have been applied to computational phantoms including 
mathematical (stylized), voxel (tomographic), and hybrid phantoms used to represent 
actual patients for dose estimation. The greatest sources of error stem from the design of 
the computational dosimetry phantoms (Fig A1.1), specifically the shape and distribution 
of organs. Monte Carlo simulation data are typically based on a standardized 
mathematical model of a human body known as the reference man (20). The International 
Commission on Radiological Protection (ICRP) defines a reference man as a Caucasian 
man that is an inhabitant of Western Europe or North America weighing 70 kg with a 
height of 170 cm (20, 21). The dimensions were obtained in the 1970s and 80s (22). 
Mathematical phantoms (also called stylized) are inherently limited because these 
phantoms contain fixed geometric shapes (elliptical cylinders, spheres, and cones) 
characterized by three-dimensional surface equations to represent patient organs (22, 23). 
The first types of computational phantoms were developed in 1960s at the Oak Ridge 
National Laboratory (ORNL) for the Medical Internal Radiation Dosimetry (MIRD) 
Committee. This phantom was classified as a hermaphrodite adult. By the 1980s, a family 
of mathematical phantoms (newborn, 1-year, 5-year, 10- year, 15-year, and adult 
phantom) was developed at ORNL based on anthropological reference data of ICRP 
publication 23 (24). These mathematical phantoms are intended to represent entire 
populations (25). However, the use of a single reference model for a specific age group 
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does not capture variations in human anatomy (26). Lee and colleagues reported organ 
dose errors up to 30% using Monte Carlo software to calculate absorbed dose when a 
mathematical reference (15-year old) phantom was used to represent overweight 15-year 
old patients (27). This error is expected to increase when the reference adult is used to 
represent overweight and obese adults. The errors in organ dose estimates are due to a 
significant amount of subcutaneous fat thickness observed in overweight and obese 
patients when compared to either a reference pediatric or adult phantom (27).  
 
 
Figure A1.1: A comparison of computational phantoms: mathematical (stylized), voxel 
(tomographic), and hybrid phantoms (54). [permission granted for reprint] 
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Compared to mathematical phantoms, voxel (also called tomographic) models 
contain more realistic three-dimensional digital representations of the shape, volume, and 
composition of human organs (22, 28). Voxel models typically rely on either CT or 
magnetic resonance images from live volunteers or cadavers to provide three-dimensional 
representations of the human body (22, 29). Voxels dimensions are then scaled to match 
the body height and weight of the reference male. An improved approach is the creation 
of a voxelized phantom from a patient’s own CT images. A patient’s CT dataset can be 
voxelated by classifing each voxel as a particular tissue type based on fixed Hounsfield 
unit (HU) values (e.g, adipose tissue (-200 to -5 HU)) (30). Voxels are then assigned a 
molecular formula and a mass density estimate based on tissue type (30) (Fig A1.2). 
 
 
Figure A1.2: Creation of a patient-specific virtual phantom from a standard attenuation 
image. Each voxel is classified as a particular material type based on fixed Hounsfield 
unit (HU) values: air (-1000 to -930 HU), lung (-930 to -200 HU), adipose tissue (-200 to 
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-5 HU), water (-5 to -5 HU), soft tissue (+5 to +40 HU), skeletal muscle (+40 to + 400 
HU), cortical bone (> +400 HU) (30).  
 
The most recent computational phantoms (hybrid) capture the advantages of both 
mathematical and voxel phantoms. Advanced mathematical descriptors, nonuniform 
rational B-spline (NURBS) and polygon mesh surfaces are used to characterize the 
boundaries of internal organs and exterior body surfaces along with the patient’s 
segmented CT images (27, 31-35). These images are enhanced with the corresponding 
body dimensions and organ masses from the international reference data in ICRP 89 (31, 
34, 36).  
 
A1.4 Estimation of Effective Dose  
A1.4.1 DLP conversion 
The European Working Group for Guidelines on Quality Criteria in CT suggested a 
simple method for the estimation of effective dose: multiplication of the scanner-
provided DLP, described above, with a standard body-region specific conversion factor 
(k-factor with units of mSv x mGy
-1
 x cm
-1
) (37). The group published six k-factors 
representing broad regions of the human body (head and neck, head, neck, chest, 
abdomen and pelvis, trunk) at five phantom ages (0 year, 1 year, 5 years, 10 years, and 
adult). K-factors were derived from the family of mathematical phantoms using Monte 
Carlo methods as described in the ICRP 60 report (38-40). Data was averaged from MC 
simulations of scanning on many different single-slice scanner makes and models (41). 
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K-factors are limited because they fail to account for patient gender, age, body habitus, 
tissue composition, organ size or shape, nor specific scanner dosimetry, all known factors 
influencing the biological effect of radiation exposure. 
 
A1.5 Monte Carlo Simulation using Reference Phantoms  
More sophisticated approaches for the estimation of effective dose require CT 
dose estimation tools such as ImPACT patient dosimetry calculator (42-44) , CT-Expo 
(42, 45), and ImpactDose (42, 46) which apply MC techniques to reference phantoms 
(26). Absorbed doses in each organ and tissue are obtained by summing all energy 
depositions from primary and scattered photons in a given organ/tissue and dividing by 
the organ/tissue mass. In 1991, two comprehensive organ dose databases were developed; 
National Radiological Protection Board (NRPB) in London and National Research Center 
for Environment and Health (GSF) in Germany based on Monte Carlo simulations that 
exist in accordance to reference dimensions of the body and organs defined by the ICRP 
(31, 32). The NRPB organ dose database was originally based on a hermaphrodite adult 
stylized phantom and the National Research Center for Environment and Health (GSF) in 
Germany was based on male and female adult stylized phantoms (ADAM and EVA) as 
well as two pediatric (8 week old classified as BABY and a 7 year old classified as 
CHILD) voxel phantoms. ADAM and EVA, a modification of the hermaphrodite MIRD 
phantoms were an updated version of the original stylized phantoms developed at the 
ORNL in the 1960s. New MC simulations were performed on a few scanner models 
(Siemens DRH, GE 9800, and Philips LX) at NRPB for a complete family of six MIRD 
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mathematical phantoms: a newborn, 1year, 5 years, 10 years, 15 years, and an adult (11) 
(Table A1.1). Meanwhile at GSF, a complete voxel family was also developed 
representing a range of patient sizes and ages from 8 weeks to 48 years of age including 
both male and female models (47) (Table A1.1). So, both databases have been updated to 
include both adult and pediatric phantoms.  
 
Oak Ridge National Laboratory (ORNL)/ National Radiological Protection Board 
(NRPB) Mathematical Reference Phantoms 
Name Gender Age Scanned Region Weight 
Newborn 
hermaphrodite 
Newborn NA 3.5 kg 
1 year 1 year NA 9.9 kg 
5 years 5 years NA 18.5 kg 
10 years 10 years NA 32.5 kg 
15 years 15 years NA 55 kg 
Adult Adult NA 70 kg 
National Research Center for Environment and Health (GSF) Voxel Reference 
Phantoms 
Name Gender Age Scanned Region Weight 
Baby F 8 weeks Whole body 4.2 kg 
Child F 7 years Whole body 21.7 kg 
Donna F 40 years Whole body 79 kg 
Helga F 26 years  Mid thigh and 
upwards 
76.8 kg 
Frank M 48 Torso and head 65.4 kg 
Golem M 38 Whole body 68.9 kg 
Visible Human M 38 From knees and 
upwards 
87.8 kg 
Table A1.1: A complete family of mathematical reference phantoms and voxel reference 
phantoms that is used by the Oak Ridge National Laboratory (ORNL), National 
Radiological Protection Board (NRPB), and the National Research Center for 
Environment and Health (GSF) (8, 55, 56) 
 
ImPACT uses 23 dosimetry datasets from 27 scanner models from the 1990s 
which are contained in the NRPB SR250 report (35, 40, 48). Modern scanners are 
matched according to dosimetry characteristics to one of the available datasets. CT-Expo 
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and ImpactDose calculators incorporate most modern CT scanners (32, 35, 49, 50). Using 
scanner-specific information, these programs allow the user to estimate organ doses and 
effective dose for a wide range of scanner and examination parameters (39).  
When MC methods are applied to a reference phantom, absorbed dose estimates 
are least accurate for patients smaller (pediatric) or larger (overweight or obese adult) 
than the reference phantoms highlighting the need for phantoms more representative of 
these groups(27). In order to provide more accurate dose estimates, overall patient size 
(51)
 
and individual organ sizes should be considered or correction factors should be 
applied when scanning patients who deviate from the 70 kg reference phantom size or 
standard pediatric phantoms (42).  
 
A1.6 Monte Carlo Simulation Using Patient Phantoms 
Monte Carlo methods can be performed on voxelized image sets to produce 
patient-specific dose maps which assign each display a pixel value representing the 
absorbed dose of the corresponding tissue voxels. Monte Carlo simulation tools 
(Diagnostic Photon Simulation [DiPhos], Philips Research, Eindhoven, Netherlands and 
ImpactMC; CT Imaging, Erlangen, Germany) typically allow modeling of the specific 
scanner characteristics (e.g., CT scanner geometry, table geometry, beam collimation, 
bow-tie filter composition) used to obtain the images.  
Dose to organs contained within the scan range are determined by segmenting the 
organ in the dose maps and summing over all pixel values contained within that organ 
(Fig A1.3). The total absorbed organ dose is multiplied with the appropriate tissue 
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weighting factor defined by the ICRP (52, 53) to obtain an equivalent dose. Equivalent 
doses for all organs are summed to estimate effective dose. Effective dose calculated 
from the dose map method highlights the limitations inherent in the standard DLP 
method. 
 
 
Figure A1.3: An example of axial CT attenuation images (bottom images) and the 
corresponding dose maps (top images) from two different patients for evaluation of 
thoracic aorta. Patient A (Male) with a BMI of 45 kg/m
2
 was imaged with a prospective 
electrocardiogram-triggered axial technique at a tube potential of 120kVp. Patient B 
(Female) with a BMI of 23 kg/m
2
 was imaged with a prospective electrocardiogram-
triggered axial technique at a tube potential of 100 kV.   
Patient A 
BMI = 45 kg/m
2 
Patient B 
BMI = 23 kg/m
2 
CT attenuation image  CT attenuation image 
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Unlike mathematical phantoms, voxelized patient phantoms contain all organs 
and tissues that are assigned a weighting factor by the ICRP. However, segmenting all the 
listed organs and tissues for each individual voxelized phantom is often impractical and 
typically effective dose is estimated by determining only dose to the most radiosensitive 
organs.  
Appropriately accounting for dose to partially irradiated organs (organs that lie 
partly in and partly out of the reconstructed scan range) is challenging with voxelized 
phantoms based on patient images. Doses determined only from directly irradiated voxels 
contained within the scan range tend to overestimate dose to the partially irradiated organ 
because the weighting factor used to calculate equivalent dose assumes exposure to the 
entire organ. For partially irradiated organs, dose should be based on a weighted sum of 
dose to directly and indirectly irradiated regions. Dose to the indirectly irradiated region 
outside the scan range must be estimated based on assumptions about the total organ 
length and knowledge of dose falloff outside the prescribed scan range. Dose estimation 
to partially irradiated organs is not limited in this way with mathematical reference 
phantoms which represent the entire body (the cranial-caudal range is not limited to the 
reconstructed scan volume).  
3D dose distribution maps created from patient images have the potential to 
account for variability (gender, body habitus, tissue composition, organ size, organ shape, 
specific scanner dosimetry) among patients not captured by reference phantoms and 
provide more patient-specific organ doses. However, estimation of effective dose requires 
multiplication with population based ICRP weighting factors. Still, estimation of 
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effective dose from voxelized patient images is more patient- and scanner-specific in 
comparison to other methods used to compute effective dose  
 
A1.7 Conclusion  
Body size and patient specific anatomy are overlooked with the use of physical phantoms 
and mathematical phantoms. Mathematical phantoms cannot be used to calculate accurate 
organ doses because organs are characterized as geometric shapes. Organ doses are 
pertinent information to include in the calculation of effective dose. Effective doses based 
on a reference phantom are routinely used to describe the risk for a specific CT scan and 
to compare that risk to other CT scans or other sources of radiation exposure. Patient-
specific dose maps are sensitive to scanner type, patient size, and organ size allowing 
estimation of organ and effective doses. Mathematical and voxels models that are based 
on reference man dimensions do not consider individuals who are smaller or larger than a 
70 kg man. Whole body hybrid phantoms are advantageous for individuals that require a 
whole body CT or MRI scan but these models are scaled according to a various ICRP 
dimensions. Plus, modeling, segmentation is quite time consuming for hybrid phantoms. 
For individuals that required specific scanned region as in chest CT or chest, abdomen 
pelvis CT exams, patient-specific dose maps are ideal.  
Use of more patient-specific methods to estimate organ and effective doses could 
lead to better metrics for CT dose management. Patient-specific organ doses can be 
estimated from patient image derived dose maps and used to determine more patient-
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specific effective dose values. However, any estimation of effective dose that uses 
population based ICRP weighting factors cannot be entirely patient-specific.  
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